Introduction {#s1}
============

Neurons form ensembles that encode experiences. This has been demonstrated in the past several decades by in vivo electrophysiological and calcium imaging experiments in which the activity of neuronal ensembles has been correlated with behavior in active animals ([@bib4]; [@bib17]). Understanding the process whereby experience is converted to long-term memory and consequent behavioral modification requires that *relevant* ensembles of neurons be defined precisely and genetically to allow functional interrogation and manipulation.

Transcription events triggered within neurons by neuronal activity are key to neural circuit plasticity, ensemble formation, and ultimately information storage ([@bib1]; [@bib6]; [@bib19]; [@bib24]). Experience-dependent transcription events thus present a promising way to genetically identify neurons responsible for encoding learned experiences in vivo. However, the transcriptional profile must fit the following two criteria: (1) very low basal expression in the absence of salient experience and (2) strong induction by neuronal activity associated with experience and behavior. Immediate early genes (IEGs) such as *Fos, Arc* and *Egr1* meet these criteria quite well ([@bib19]), and their promoters have been used to control the expression of effector genes such as fluorescent proteins and opsins in genetically engineered mouse lines, allowing active ensemble labeling and functional perturbation, respectively ([@bib2]; [@bib18]; [@bib30]; [@bib49]; [@bib56]; [@bib60]; [@bib11]; [@bib10]). However, significant technical obstacles greatly limit the usability of these systems.

The biggest challenge is to improve the sensitivity and selectivity of neuronal ensemble identification. Existing systems suffer from high background, i.e. labeling of neurons unrelated to the experimental stimulus of interest, which confounds precise identification of the relevant active ensemble. The level of background labeling is determined by the characteristics of the IEG promoter used and the method of temporal control used to isolate events happening within a desired experimental time window. Therefore, to address the problem of background labeling, we wanted to develop an IEG-sensitive promoter with an optimized activity-dependent induction profile and incorporate it into a platform with improved temporal control of effector gene expression.

In addition, the use of transgenic reporter lines in existing systems requires laborious breeding and is experimentally inflexible. Therefore, we also aimed to develop a system in which both the activity-dependent transcription component and the effector genes for neural circuit interrogation are delivered using a single adeno-associated virus (AAV). In addition to bypassing the requirement for multiple transgenic mouse lines, an entirely viral system can also be used in species other than the mouse.

Here we present a virus-based platform for the analysis of active neuronal ensembles, which we call the Robust Activity Marking (RAM) system. The following features of the RAM system make it highly selective, sensitive, and versatile: (1) a synthetic neuronal activity-dependent promoter with very low expression in basal conditions prior to a designated experience and strong induction by neural activity during the experience for robust ensemble labeling; (2) a modified Tet-Off system that provides improved temporal control; (3) small size, well within the packaging limit of a single AAV; (4) modular design so that the promoter and effector genes can be easily substituted to address different experimental questions; and (5) proven transferability to species other than the mouse, making it a valuable tool for the wider neuroscience community. We demonstrate the use of the RAM system to interrogate active neuronal ensembles in several different regions of the murine and drosophila brain.

Results {#s2}
=======

Design of a synthetic activity-regulated promoter {#s2-1}
-------------------------------------------------

To find a small promoter broadly responsive to neuronal activity, we searched for highly enriched DNA elements among 11,830 previously identified neuronal activity-regulated enhancers ([@bib28]). The Activator Protein 1 (AP-1) site (TGANTCA), a consensus sequence for the FOS/JUN family transcription factors, was initially identified as the most highly enriched motif ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We further considered that multiple transcription factors often bind enhancers co-operatively or competitively to tightly regulate gene expression in a combinatorial manner ([@bib21]). We therefore tried combining the AP-1 site with the binding motif of the neuronal-specific activity-dependent gene *Npas4* ([@bib47]) (NRE: TCGTG) to increase the sensitivity and specificity of our promoter.

We inserted the core NRE/AP-1 DNA motifs into the central midline element (CME), a characterized transcriptional regulatory sequence whose secondary structure is favorable for transcription activation ([@bib62]), resulting in a 24 bp \'enhancer module.\' Unless otherwise stated, we assembled promoters by placing four tandem repeats of an enhancer module upstream of the human *FOS* minimal promoter, resulting in a 199 bp synthetic promoter ([Figure 1a](#fig1){ref-type="fig"}). We assayed both the absolute transcriptional strength, reflected by the relative luciferase value, and the activity dependence and sensitivity, represented by the fold induction between stimulated and unstimulated conditions, of the synthetic promoters using dual luciferase assay in cultured neurons (See 'Methods' for details).10.7554/eLife.13918.003Figure 1.Design and characterization of the RAM promoter (P~RAM~) and AAV-based RAM system in vitro.Unless indicated otherwise, cultured mouse hippocampal neurons were transfected with luciferase reporter constructs on DIV5 and stimulated with 35 mM KCl for 6 hr on DIV 7 or 8 (See [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} for details). The relative luciferase value is the absolute luciferase value normalized against the internal control. The fold induction is the ratio of the relative luciferase values in stimulated and unstimulated conditions. (**a**) P~RAM~ has higher fold induction than promoters in which the NRE/AP-1 element is replaced by other elements found enriched in the 11,830 activity-regulated enhancers (See 'Methods'). CME is not regulated by activity. Each construct contains four enhancer modules (EM) inserted upstream of the *FOS* minimal promoter (left). The relative luciferase values are shown in [Figure 1---figure supplement 2b](#fig1s2){ref-type="fig"}. n = 5--7 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. (**b**) The robust activity response of P~RAM~ is a result of the combination of the four repeated RAM EM and *FOS* minimal promoter, which alone are respectively weakly responsive or non-responsive to neuronal activity. n = 5--10 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. (**c**) Comparison of P~RAM~ to various activity-dependent promoters. Promoter size (Kb) is shown in brackets. The relative luciferase values are shown in [Figure 1---figure supplement 3a](#fig1s3){ref-type="fig"}. n = 4--10 separate experiments per condition, Student's t-test. (**d**) Comparison of P~RAM~ and ESARE. n = 6--8 separate experiments per condition, Student's t-test. (**e**) P~RAM~ can be driven by overexpression of FOS and NPAS4 individually or in combination. n = 9--10 separate experiments per condition, one-way ANOVA, Dunnett's post-hoc test. (**f**) Top, schematic outline of Tet-OFF system with P~RAM~ driving tTA expression. Binding of tTA protein to the TRE promoter is prevented by Dox administration (+Dox); withdrawal of Dox (-Dox) allows downstream effector gene transcription. Bottom, schematic diagram of the AAV-RAM construct with critical genetic elements outlined. (**g**) Comparison of P~RAM~-d2tTA and P~RAM~-tTA by assaying pTRE-luciferase activity with and without Dox (+Dox, −Dox). The relative luciferase values are shown in [Figure 1---figure supplement 3e](#fig1s3){ref-type="fig"}. n = 3 separate experiments per condition, Student's t-test. (**h**) Representative images of hippocampal neurons grown on a glia monolayer and infected with AAV-RAM-tdTomato (red). Neurons are identified by MAP2 staining (green). Cultures were either left undisturbed (No Stim) or stimulated with bicuculline and 4AP (+Bic/4AP), either with (+Dox) or without (-Dox) doxycycline added. The scale bar is 150 μm and applies to all images. (**i**) Quantification of **h**. Percentages of neurons (MAP2+) that are RAM+ (%RAM+) are plotted. n = 3 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. All data in **a**--**e**, **g** and **i** are mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.003](10.7554/eLife.13918.003)10.7554/eLife.13918.004Figure 1---figure supplement 1.Position-weight matrix of the top-ranking motif (AP-1, TGANTCA) identified by a Weeder de novo motif search.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.004](10.7554/eLife.13918.004)10.7554/eLife.13918.005Figure 1---figure supplement 2.Characterization of enhancers by luciferase assay.(**a**) Fold induction with P~RAM~ and P~NRE+AP-1~ constructs following 6 hr of KCl stimulation. n = 4--10 separate experiments per condition, Student's t-test, \*p\<0.05. (**b**) Relative luciferase activity with P~RAM~, enriched enhancers E1-E3 and CME constructs following 6 hr of KCl stimulation. Note log~10~ scale. Baseline activity is similar for all constructs (non-significant difference). For KCl conditions P~RAM~ displays significantly higher activity than CME, E2 and E3 (\*p\<0.05, \*\*\*p\<0.001) and E1 displays significant higher activity than CME and E2 (♯p\<0.05, ♯♯p\<0.01). CME construct expression is not induced by depolarization. n = 5--7 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. The fold induction is shown in [Figure 1c](#fig1){ref-type="fig"}. (**c**) Fold induction with constructs containing four RAM enhancer modules attached to the following minimal promoters: CMV: cytomegalovirus; hBG: human beta-globin; *Arc*: activity-dependent cytoskeleton associated-protein. n = 5--12 separate experiments per condition, one-way ANOVA, Dunnett's post-hoc test. (**d**) Fold induction with P~RAM~ constructs containing different numbers of RAM enhancer modules. n = 5--12 separate experiments per condition, one-way ANOVA, Dunnett's post-hoc test. Data in **a**--**d** are mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, *n.s.*, non-significant.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.005](10.7554/eLife.13918.005)10.7554/eLife.13918.006Figure 1---figure supplement 3.Characterization of the P~RAM~ promoter in vitro.(**a**) Relative luciferase activity of activity-dependent promoters. Note log~10~ scale. Statistically significant differences between baseline conditions (No Stim) are indicated by \* and between KCl conditions by \#. All other comparisons are non-significant. n = 4--10 separate experiments per condition, Student's t-test. The fold induction is shown in [Figure 1c](#fig1){ref-type="fig"}. (**b**) Relative luciferase activity of P~RAM~ following bicuculline (Bic) stimulation and blocking with Nimodipine and/or APV. n = 4 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. (**c**) Relative luciferase activity of P~RAM~ after 6 hr of stimulation with various growth factors and pharmacological agents. n = 4 separate experiments per condition, Student's t-test. (**d**) Relative luciferase activity of P~RAM~ in pure glial cultures following 4 hr of KCl stimulation. n = 2 separate experiments per condition. (**e**) Relative luciferase activity of P~RAM~-tTA- and P~RAM~-d2tTA-mediated pTRE-luciferase transcription with and without KCl stimulation, and with and without Dox (+Dox, -Dox). The fold induction is shown in [Figure 1g](#fig1){ref-type="fig"} . n = 3 separate experiments per condition, Student's t-test. Data in **a**--**e** are mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, *n.s.*, non-significant.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.006](10.7554/eLife.13918.006)10.7554/eLife.13918.007Figure 1---figure supplement 4.Quantification of AAV-RAM-tdTomato infection of neuron-glia co-cultures determined by immunocytochemistry.(**a**) Percentage of MAP2+ cells expressing tdTomato (RAM+) at various amounts of virus applied per well. Experiments in **b** and [Figure 1h--i](#fig1){ref-type="fig"} used 0.1 μl/well (red bar). n = 3 separate experiments per condition. (**b**) Co-labeling of MAP2 or GFAP with tdTomato (RAM+). GFAP did not co-label with tdTomato. N = 3 separate experiments per condition. All data in **a**--**b** are mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.007](10.7554/eLife.13918.007)

The relative position of the NRE and AP-1 sites turned out to be critical. When these motifs partially overlapped by two base-pairs to form a 10mer TCG**[TG]{.ul}**ANTCA, the resulting synthetic promoter had the strongest activity-dependent induction profile ([Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). We named this promoter P~RAM~. The CME alone was not responsive to activity ([Figure 1a](#fig1){ref-type="fig"}). Furthermore, P~RAM~ performance was not improved by replacing the NRE/AP-1 element with other highly enriched AP-1 containing 10mers found in the 11,830 neuronal activity-regulated enhancers, indicating the significance of the NRE and AP-1 combination in our design ([Figure 1a](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2b](#fig1s2){ref-type="fig"}). In general, we found no correlation between 10mer enrichment and fold induction in the luciferase assay ([Figure 1a](#fig1){ref-type="fig"}, [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}).

We proceeded with further characterization of P~RAM~ and found that removing or substituting the minimal promoter ([Figure 1b](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2c](#fig1s2){ref-type="fig"}), or changing the number of enhancer modules substantially reduced the fold induction ([Figure 1---figure supplement 2d](#fig1s2){ref-type="fig"}). When compared to several other activity-regulated promoters, P~RAM~ had among the highest fold induction ([Figure 1c](#fig1){ref-type="fig"}) and the highest relative luciferase activity in response to neuronal stimulation ([Figure 1---figure supplement 3a](#fig1s3){ref-type="fig"}). We compared P~RAM~ to another recently developed synthetic activity-dependent promoter, ESARE, which was based on the promoter of the IEG *Arc* ([@bib25]). ESARE had a significantly lower fold induction, due to its high basal activity ([Figure 1d](#fig1){ref-type="fig"}). Notably, P~RAM~ has by far the largest fold induction of any activity-dependent promoter small enough to be packaged into an AAV.

We next verified that P~RAM~ has the characteristics expected from the presence of the FOS and NPAS4 binding motifs. Indeed, over-expression of FOS, NPAS4, or both proteins in combination was sufficient to drive transcription through P~RAM~ ([Figure 1e](#fig1){ref-type="fig"}). Expression from P~RAM~ was strongly induced by Ca^2+^ influx ([Figure 1---figure supplement 3b](#fig1s3){ref-type="fig"}) and by various growth factors known to induce *Fos* expression ([@bib34]) ([Figure 1---figure supplement 3c](#fig1s3){ref-type="fig"}). When expressed in glia, P~RAM~ had minimal basal activity and no activity-dependent induction ([Figure 1---figure supplement 3d](#fig1s3){ref-type="fig"}). We concluded that P~RAM~ is a neuron-specific and highly activity-dependent promoter.

The RAM system: a modular bicistronic AAV vector with optimized temporal control of gene expression {#s2-2}
---------------------------------------------------------------------------------------------------

We next constructed the RAM system, incorporating P~RAM~ into the doxycycline-dependent Tet-Off system ([@bib16]). Specifically, P~RAM~ drives the expression of the tetracycline transactivator (tTA), which efficiently activates the tTA-responsive element (TRE) promoter driving the effector gene cassette. Binding of tTA to TRE can be blocked by administration of the antibiotic doxycycline (Dox), preventing expression of the effector gene ([Figure 1f](#fig1){ref-type="fig"}) and allowing temporal control of gene expression.

Our preliminary evaluation of the conventional Tet-Off system showed that the accumulation of tTA outside of the designated experimental window contributed to the undesirable background expression of effector genes. We therefore created a destabilized version of tTA, d2tTA, by fusing the degradation domain of mouse ornithine decarboxylase (MODC) to the N-terminus of tTA. Using a luciferase assay after co-transfecting a TRE-luciferase plasmid with either P~RAM~-tTA or P~RAM~-d2tTA into cultured neurons, we found that using d2tTA led to significantly lower basal expression ([Figure 1---figure supplement 3e](#fig1s3){ref-type="fig"}), tighter Dox regulation ([Figure 1g](#fig1){ref-type="fig"}), and improved fold induction by a factor of 7--8 compared with conventional tTA ([Figure 1g](#fig1){ref-type="fig"}). [Figure 1f](#fig1){ref-type="fig"} shows the final design of the RAM system AAV vector. Due to the compact design and small size of P~RAM~, all the necessary components fit within the packaging limit of a single AAV vector (4.9 Kb) with room for an effector gene of up to 1.8 Kb in size.

We validated the RAM system first in cultured neurons, using the red fluorophore tdTomato (tdT) as the effector gene. Using an optimized titer of AAV-RAM-tdT ([Figure 1---figure supplement 4a](#fig1s4){ref-type="fig"}), close to 100% of cultured mouse hippocampal neurons were infected at DIV7. With Dox absent throughout, at DIV14 approximately 5% of neurons (MAP2-positive cells) were labeled with tdT under unstimulated conditions, while nearly 90% of neurons were labeled following bicuculline (Bic) and 4-aminopyridine (4AP) stimulation ([Figure 1h--i](#fig1){ref-type="fig"}). RAM labeling was tightly controlled by Dox, with no labeling cells detected when Dox was present after infection ([Figure 1h--i](#fig1){ref-type="fig"}). No glial cells were tdT positive ([Figure 1---figure supplement 4b](#fig1s4){ref-type="fig"}). Thus, our AAV-based RAM system showed strong induction and low background, as desired.

Optimizing in vivo labeling using the RAM system {#s2-3}
------------------------------------------------

We carried out a series of experiments to determine optimal working parameters for our AAV-based RAM system in vivo. For these experiments, we chose the nuclear localized, red-shifted fluorophore NLS-mKate2 as the effector gene. For all in vivo experiments in mice, AAV-Ef1α-EGFP, which constitutively expresses EGFP in infected neurons, was co-injected as an infection control. The titer of the EGFP control virus was adjusted so that nearly 100% of neurons at the injection site were infected. To optimize the RAM virus, animals were placed on a Dox diet 24 hr before viral injection into the hippocampus, and allowed to recover for at least 7 days before administration of kainic acid to induce seizures, which robustly stimulates the limbic system and fully activated P~RAM~ in the majority of AAV-RAM infected neurons. With an optimized titer, more than 90% of EGFP+ neurons were also RAM+ after seizure. Using this setup, we found that animals should optimally be off Dox for 24--48 hr before behavioral manipulation (in this case the manipulation was seizure, [Figure 2a--d](#fig2){ref-type="fig"}), and that effector gene expression peaked within 24 hr following behavioral manipulation ([Figure 2a,e--g](#fig2){ref-type="fig"}). In addition, a further expression of the effector gene was completely blocked 24 hr after the animals were placed back on Dox chow ([Figure 2---figure supplement 1a--d](#fig2s1){ref-type="fig"}).10.7554/eLife.13918.008Figure 2.Optimizing the working parameters for the AAV-RAM system in vivo.(**a**) Schematic of the hippocampus showing the CA1, CA3 and DG regions with the injection site (DG) highlighted in blue. (**b**--**d**) Experiments to determine the time required for Dox clearance to allow maximal effector gene expression. (**b**) Experimental scheme. Animals were co-infected with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP and kept on Dox diet (+Dox) for a minimum of 7 days. The animals were taken off Dox diet (−Dox) 12, 24, or 48 hr before kainic acid treatment to induce seizures and sacrificed 24 hr after this treatment. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the DG stratum granulosum when seized 12, 24 or 48 hr after Dox removal. n = 3--4 animals per group, one-way ANOVA, Tukey's post-hoc test. (**d**) Representative images from the data quantified in **c**. The scale bar is 150 μm and applies to all images. (**e**--**g**) Experiments to determine the maturation of effector gene expression. (**e**) Experimental scheme. Animals were treated similarly to **a**, and 48 hr following Dox removal (-Dox), animals were seized then sacrificed 3, 6, 12, or 24 hr later. (**f**) Percentage of RAM+ cells among total EGFP+ cells in the DG stratum granulosum 3, 6, 12, or 24 hr after seizure. RAM+ cells are detected by fluorescence (mKate2, red) or immuno-staining (α-mKate2, cyan). n = 2--4 animals per group, two-way ANOVA, Bonferroni post-hoc test. (**g**) Representative images from the data quantified in **f**. Upper row: AAV-mKate2 (red), middle row: mKate2 detected by antibody (α-mKate2, cyan), lower row: EGFP (green). The scale bar is 150 μm and applies to all images. Data in **c** and **f** are mean ± SEM. \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.008](10.7554/eLife.13918.008)10.7554/eLife.13918.009Figure 2---figure supplement 1.Rapid suppression of RAM expression on returning to Dox diet.(**a**) Schematic timeline of the experimental procedure. Animals were co-injected with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into DG and kept on Dox diet (+Dox) for a minimum of 7 days. Dox was withdrawn (−Dox) for 48 hr then resumed for 0, 24 or 48 hr prior to kainic acid treatment to induce seizures. Animals were sacrificed 24 hr after seizure induction. (**b**) Schematic drawing of the hippocampus showing the viral injection site. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the DG with 0, 24 or 48 hr Dox blockade before seizure. n = 3--4 animals per condition, one-way ANOVA, Tukey's post-hoc test. (**d**) Representative images from the data quantified in **c** showing mKate2 (red) and EGFP (green) labeling. The scale bar is 150 μm and applies to all images.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.009](10.7554/eLife.13918.009)

Labeling active ensembles in the hippocampus {#s2-4}
--------------------------------------------

We next tested the ability of RAM to label neuronal ensembles activated by salient experience, using contextual fear conditioning (CFC) as a model behavioral paradigm. Animals were kept on Dox chow for at least 1 week after viral injection, switched to Dox-free chow 48 hr before CFC, and sacrificed 24 hr after CFC ([Figure 3a](#fig3){ref-type="fig"}). First we virally targeted the dentate gyrus (DG) sub-region ([Figure 3b](#fig3){ref-type="fig"}), which is known to express IEGs after CFC ([@bib35]). Each cohort of animals was divided into the following five treatment groups: (1) left unperturbed in the home cage (HC), (2) CFC, (3) exposed to the novel context only without shock (Context Only) and (4) exposed to immediate shocks (Shock Only) and (5) kainic acid-induced seizure ([Figure 3c--d](#fig3){ref-type="fig"}). We quantified the percentage of EGFP+ cells that were RAM+ (labeled with NLS-mKate2) in each treatment group. We found a significant increase in RAM+ cells in both the CFC and Context Only group, compared to the HC animals ([Figure 3c](#fig3){ref-type="fig"}). Importantly, RAM labeled a very similar number of DG neurons in animals exposed to Context Only as in those that underwent CFC ([Figure 3c](#fig3){ref-type="fig"}), which is consistent with published studies showing that the hippocampus forms contextual representations independent of shock delivery ([@bib52]; [@bib12]) and that similar levels of IEG induction occur for these two conditions ([@bib47]). Furthermore, the Shock Only condition did not induce RAM activation at all ([Figure 3c](#fig3){ref-type="fig"}), suggesting that RAM labeling was specific to neuronal ensembles involved in contextual learning. Interestingly, such learning-specific induction is one of the unique properties of *Npas4* ([@bib47]; [@bib58]). These results suggest that the RAM system labels an active population of cells in an experience-dependent manner. Importantly, mice that were kept on Dox chow throughout CFC treatment showed a complete lack of RAM+ cells in the DG ([Figure 3---figure supplement 1a--b](#fig3s1){ref-type="fig"}).10.7554/eLife.13918.010Figure 3.The RAM system labels active neuronal ensembles in the DG of the hippocampus.(**a**) Schematic timeline of the experimental procedure. Animals were kept on Dox diet (+Dox) from 24 hr before injection of AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into DG to a minimum of 7 days after the injection. Dox was then withdrawn (−Dox) 48 hr before either CFC, exposure to the novel context without shock (Context Only), receiving immediate shocks (Shock Only) or kainic acid treatment to induce seizures. Animals were sacrificed 24 hr later. A control cohort of similarly injected and treated animals was left undisturbed in their home cages (HC) for the entire period before sacrifice. (**b**) Schematic drawing of the hippocampus with the viral injection site (DG) highlighted in blue. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the DG stratum granulosum for HC, CFC, Context Only, Shock Only and seized animals. The data for seized animals are replotted from [Figure 2c](#fig2){ref-type="fig"} (48 hr group). n = 6--9 animals per condition (with the exception for the Shock Only group, which consisted of 3 animals), one-way ANOVA, Tukey's post-hoc test. (**d**) Representative images of the DG region showing mKate2 (red) and EGFP (green) labeling for each of the HC, CFC, Context Only, Shock Only and seizure conditions. The scale bar is 300 μm for the left images and 50 μm for the three right columns of images. These images are enlarged from the areas marked by purple squares. All data in **c** are mean ± SEM. \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.010](10.7554/eLife.13918.010)10.7554/eLife.13918.011Figure 3---figure supplement 1.RAM labeling in the hippocampus following sensory experience is prevented by Dox diet.(**a**) Schematic timeline of the experimental procedure. Following injection of AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into DG, animals were left on Dox diet (+Dox) throughout. Animals were subjected to CFC and sacrificed 24 hr later. (**b**) Representative images of the DG from animals given CFC treatment. Left: mKate2 (red). Right: EGFP (green), DAPI (blue) and mKate (red) merged. No RAM+ positive cells were detected. The scale bar is 150 μm and applies to both images. n = 4 animals.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.011](10.7554/eLife.13918.011)10.7554/eLife.13918.012Figure 3---figure supplement 2.RAM labeling of CA3 pyramidal cells following contextual fear conditioning (CFC).(**a**) Schematic timeline of the experimental procedure. Animals were kept on Dox diet (+Dox) from 24 hr before injection of AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP vectors into CA3 for a minimum of 7 days after the injection. Dox was then withdrawn (−Dox) 48 hr before CFC or kainic acid treatment to induce seizures. Animals were sacrificed 24 hr after CFC or seizure induction. A control cohort of similarly injected and treated animals was left undisturbed in their home cages (HC) for the entire period before sacrifice. (**b**) Schematic drawing of the hippocampus with the injection site (CA3) highlighted in blue. (**c**) Representative images of the CA3 region showing mKate2 (red) and EGFP (green) and DAPI (blue) labeling for HC, CFC and seizure conditions. Red arrows indicate RAM and EGFP double-labeled cells in CA3. The scale bar is 75 μm for the upper and middle (small) images and 50 μm for the lower images. The lower images are enlarged from the areas marked by purple squares. (**d**) Percentage of RAM+ cells among total EGFP+ cells in the CA3 stratum pyramidale for HC, CFC and seizure conditions. n = 3--4 animals per condition, Student's t-test. All data are mean ± SEM. \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.012](10.7554/eLife.13918.012)10.7554/eLife.13918.013Figure 3---figure supplement 3.RAM labeling following CFC persists for at least a week.(**a**) Schematic timeline of the experimental procedure. Following infection of AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into DG, animals were kept on Dox diet (+Dox) for a minimum of 7 days. Dox was withdrawn (−Dox) 48 hr before CFC. Animals were either sacrificed 24 hr later, or placed back on Dox diet for 1, 2 or 4 weeks before sacrifice. (**b**) Schematic diagram of the hippocampus showing the viral injection site. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the DG stratum granulosum for CFC animals sacrificed 24 hr or 1, 2 or 4 weeks after CFC. Data are mean ± SEM. n = 3--4 animals per condition, one-way ANOVA, Tukey's post-hoc test, \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, *n.s.*, non-significant. (**d**) Representative images of mKate2 (red) and EGFP (green) expressing cells 24 hr and 1, 2 and 4 weeks after CFC. The scale bar is 150 μm and applies to all images.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.013](10.7554/eLife.13918.013)10.7554/eLife.13918.014Figure 3---figure supplement 4.Infection with RAM-channelrhodopsin (ChR2) or -archaerhodopsin (ArchT) prior to CFC enables light-activation or silencing, respectively, of repeated action potentials in RAM+ hippocampal DG granule cells.(**a**) Schematic timeline of the experimental procedure. Animals were co-injected with AAV-RAM-ChR2:EYFP and AAV-TRE-mCherry or AAV-RAM-ArchT:EGFP and AAV-TRE-mCherry into the DG. mCherry was used for visual location of RAM+ cells during ex vivo electrophysiology. Animals were kept on Dox diet (+Dox) for a minimum of 7 days. Dox was withdrawn (−Dox) 48 hr before CFC, and animals were sacrificed 24 hr after CFC for electrophysiology. (**b**) Schematic diagram of the experimental procedure. 455 nm blue light for ChR2 activation was applied through an optical lens (40x objective). Only cells in the DG stratum granulosum were used for recording. (**c**) Photocurrent generated in a representative ChR2-RAM+ cell held at −70 mV in a voltage clamp when illuminated for 1s with blue light. (**d**) Quantification of the instant maximum (max) and constant photocurrents generated in ChR2-RAM+ cells. n = 9 cells from 3 animals. Data are mean ± SEM. (**e**) Repeated action potential evoked by 10 ms light pulses applied at 5 Hz to a ChR2-RAM+ cell held at its resting membrane potential, −75 mV, in current clamp mode. (**f**) Examples of RAM+ cells expressing ChR2-EYFP (green) and mCherry (red) in the granule cells layer and their merged image (together with DAPI, blue) as seen in a 300 μm slice used for electrophysiology. The scale bar is 20 μm and applies to all images. (**g**) As for **b**, but with 565 nm green light for ArchT activation. (**h**) Example of a photocurrent generated in ArchT-RAM+ cells held at −70 mV. (**i**) Quantification of constant photocurrents generated in ArchT-RAM+ cells. Data are mean ± SEM. n = 10 cells from 3 animals. (**j**) Light-mediated silencing of action potentials in an RAM-ArchT+ cell depolarized by an 80pA square current pulse from its resting membrane potential of −71 mV.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.014](10.7554/eLife.13918.014)

We repeated these experiments in the CA3 sub-region of the hippocampus and saw robust activity-dependent induction of RAM labeling after CFC along with low HC expression, consistent with a previous report of IEG expression in this region ([@bib18]) ([Figure 3---figure supplement 2a--d](#fig3s2){ref-type="fig"}). Interestingly, CFC treatment resulted in RAM+ labeling of 11.4% of infected CA3 pyramidal neurons, compared with 4.4% of infected DG granule cells, similar to published percentages of cells labeled by IEGs in response to CFC in these regions ([@bib31]; [@bib32]).

To determine how long expression of the effector gene persists, animals were placed back on Dox 24 hr following CFC, and mKate2 labeling was measured in the following weeks. Labeling persisted for at least 1 week with no noticeable signal loss, began to decay at 2 weeks and was undetectable after 4 weeks ([Figure 3---figure supplement 3a--d](#fig3s3){ref-type="fig"}). To test whether the RAM system drives effector gene expression sufficiently for functional manipulation the following day, we injected AAV-RAM-ChR2 or AAV-RAM-ArchT, which expressed activating channelrhodopsin and inhibiting archeorhodopsin, respectively, into the DG. Ex vivo slice recordings of sparsely RAM+ labeled dentate granule cells 24 hr after CFC revealed that active ensembles could be activated or inhibited by light ([Figure 3---figure supplement 4a--j](#fig3s4){ref-type="fig"}), paving the way for future functional manipulation of neuronal ensembles labeled by the RAM system.

Validating functional relevance of RAM+ ensembles {#s2-5}
-------------------------------------------------

We next designed experiments to test whether the active ensembles of neurons labeled by RAM are tightly associated with specific experiences. Because ensembles activated by different contexts can be distinguished within the DG region ([@bib35]; [@bib15]), and ensembles activated by a particular context are preferentially re-activated following re-exposure to the same context ([@bib2]; [@bib49]; [@bib35]; [@bib7]; [@bib26]; [@bib63]), we chose to focus on active ensembles in the DG following CFC.

We co-injected AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into the DG and kept animals on Dox chow until 48 hr before CFC. The animals were then subjected to CFC in an initial context, context A, and the neuronal ensemble activated by this first exposure was labeled by RAM. Twenty-four hours later, animals were re-exposed to context A or to a novel context B. Animals were sacrificed 1.5 hr later and brain sections were stained for the IEGs FOS and NPAS4 to label ensembles triggered by the second context exposure ([Figure 4a--b](#fig4){ref-type="fig"}). Mice re-exposed to the conditioning context A froze significantly more than those exposed to the novel context B, suggesting that mice could distinguish between the two contexts ([Figure 4g](#fig4){ref-type="fig"}).10.7554/eLife.13918.015Figure 4.Contextual memory recall preferentially reactivates cells initially labeled with RAM during memory encoding.(**a**) Schematic drawing of the hippocampus with the viral injection site (DG) highlighted in blue. (**b**) Timeline of the experimental procedure. Animals were injected with AAV-RAM-NLS-mKate2 and kept on a Dox diet (+Dox) for at least 7 days after surgery. Two days after Dox removal (−Dox), animals were exposed to context A (for RAM labeling) and shocked, and then exposed to either context A again or a new context B 24 hr later (for IEG labeling). Animals were sacrificed 1.5 hr after the second context exposure. (**c**, **d**) Representative images of DG after A−A (**c**) and A−B (**d**) exposure showing DAPI staining (cyan), FOS staining (green), RAM labeling (red), and the merged image. (**e**, **f**) As panels **c** and **d**, except staining with NPAS4 (white) instead of FOS. (**g**) Freezing behavior observed during re-exposure to context A or B. n = 4--5 animals per condition, Student's t-test. (**h**) Percentage of all DAPI-labeled cells (i.e. all neurons) in the DG stratum granulosum labeled with RAM (red) and FOS (green; n = 9 animals per condition), and the percentage overlap between the RAM and FOS labeled cells following A-A exposure (n = 4 animals) and A-B exposure (n = 5 animals). Student's t-test. (**i**) As **h**, except with NPAS4 (white) instead of FOS. The scale bar is 50 μm for all images. Data in **g**--**i** are mean ± SEM. \*p\<0.05, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.015](10.7554/eLife.13918.015)

We quantified the degree of overlap between the RAM-labeled and IEG-labeled ensembles. If RAM specifically labels the neuronal ensemble encoding a particular context, we would expect to see more overlap after repeat exposure to the same context than after subsequent exposure to a new context. Indeed, the percentage overlap between RAM+ and either FOS+ or NPAS4+ granule cells (GCs) was significantly higher in animals re-exposed to the same context A than in those subsequently exposed to the new context B ([Figure 4c--f,h--i](#fig4){ref-type="fig"}). This suggests that RAM accurately labels neurons that are involved in processing specific context information. Additionally, the absolute percentage of RAM+ or IEG+ GCs was in the 2--4% range ([Figure 4h--i](#fig4){ref-type="fig"}), similar to previous results for this brain region following context exposure ([@bib15]; [@bib48]). These results indicate that the RAM system labels an active neuronal population similar to that identified by traditional IEG staining. Furthermore, the overlap percentage between RAM+ and IEG+ GCs for context A-A exposed animals was either on par with or significantly higher than overlap percentages shown in equivalent experiments from previously published studies. Furthermore, the roughly two-fold increase in overlap percentage between context A−A and context A−B exposed animals is also on par with previously published studies ([@bib10]; [@bib48]; [@bib9]). This suggests that the RAM system can also be used for functional perturbation studies dependent on context discrimination ([@bib35]; [@bib15]; [@bib48]; [@bib29]; [@bib3]).

Application of the RAM systems to another brain region - amygdala {#s2-6}
-----------------------------------------------------------------

We next tested the versatility of our RAM system by applying it to other brain regions. We injected AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into the lateral section (LA) of the basolateral amygdala ([Figure 5a--b](#fig5){ref-type="fig"}), which is the main input locus of the amygdala for auditory afferents. We examined RAM labeling in this region in animals subjected to tone-fear conditioning (TFC), a form of cued associative learning known to require the amygdala ([@bib41]). Each cohort of animals was divided into the following four treatment groups: (1) left unperturbed in the home cage (HC), (2) TFC, (3) exposed to the tone alone without shock (Tone) and (4) received the immediate shock alone and removed from the testing chamber right away (Shock). Compared to HC controls, TFC led to a dramatic increase in the number of RAM+ neurons in the LA ([Figure 5c,f](#fig5){ref-type="fig"}). Interestingly, neither Tone nor Shock treatment alone resulted in RAM labeling significantly above the HC level ([Figure 5c,f](#fig5){ref-type="fig"}). The relative levels of RAM labeling in LA under each condition were very similar to those of IEG staining reported in published studies ([@bib55]; [@bib36]; [@bib46]). Furthermore, long-term synaptic plasticity is known to occur in the LA following TFC to allow the formation of the tone-associated fear memory, while tone or shock alone does not result in long-term behavioral or synaptic changes ([@bib51]; [@bib50]). Our result ([Figure 5c,f](#fig5){ref-type="fig"}) therefore suggests that the neuronal ensembles labeled by RAM are likely involved in fear memory formation.10.7554/eLife.13918.016Figure 5.The RAM system labels active neuronal ensembles in the amygdala.(**a**) Schematic timeline of the experimental procedure. While on a Dox diet (+Dox), AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP vectors were injected into the lateral amygdala (LA, b), basal nucleus (BA, d), or central amygdala (CeA, g). After at least 7 days, Dox was removed (-Dox) for 48 hr, the animals were exposed to tone-fear conditioning (TFC; consisting of Tone and Shock, T+S), Tone only, or Shock only and sacrificed 24 hr later. A control cohort of similarly injected and treated animals was left undisturbed in their home cages (HC) for the entire period before being sacrificed. (**b**) Schematic drawing of the amygdala with the injection and the quantification site (LA) highlighted in blue. (**c**) Percentage of RAM+ cells among total EGFP+ cells in LA for HC, T+S, Tone, and Shock animals. n = 3--6 animals per condition, one-way ANOVA, Tukey's post-hoc test. (**d**) As panel **b**, but for the BA region. (**e**) Percentage of RAM+ cells among total EGFP+ cells in BA for HC, T+S, Tone and Shock animals. n = 3--4 animals per condition, one-way ANOVA, Tukey's post-hoc test. (**f**) Representative images of neurons labeled in LA and BA for HC, T+S, Tone and Shock conditions. Neurons labeled by AAV-RAM-mKate2 are red and cells labeled by AAV-Ef1α-EGFP are green. The merged left image is enlarged in the two right images. Red arrows indicate RAM and EGFP double-labeled cells. The scale bar is 300 μm and 50 μm for left and right images, respectively. (**g**) As panel **b**, but for the CeA region. (**h**) Percentage of RAM+ cells among total EGFP+ cells in CeA for HC and T+S animals. n = 3 animals per condition, Student's t-test. (**i**) Representative images of neurons labeled in CeA region. The scale bar is 150 μm for all images. All data in **c**, **e **and **h** are mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.016](10.7554/eLife.13918.016)

In the same set of the TFC experiment, we also targeted the basal nucleus (BA) of the BLA ([Figures 5a](#fig5){ref-type="fig"},[6d--f](#fig6){ref-type="fig"}), which is a main target of LA and relays information from LA to the central amygdala (CeA). Like in the LA, TFC greatly increased the number of RAM labeled neurons in the BA, compared to HC ([Figure 5e--f](#fig5){ref-type="fig"}). In addition, the numbers of RAM labeled neurons in both Tone and Shock groups, although significantly lower than in the TFC group, were much greater than in HC ([Figure 5e--f](#fig5){ref-type="fig"}). Again, the relative levels of RAM labeling in BA were in agreement with those of IEG expression previously reported under similar conditions ([@bib55]; [@bib36]; [@bib46]).

Because our TFC condition setup also contained the novel context component, as animals were not habituated to the testing chamber, we also examined RAM labeling in the CeA, a region that has been shown to have increased IEG expression following fear conditioning ([@bib46]; [@bib20]; [@bib38]; [@bib8]). In animals subjected to TFC, the neuronal ensembles labeled by RAM in the CeA were significantly larger compared to HC ([Figure 5g--i](#fig5){ref-type="fig"}). Taken together, these results indicated RAM can label neuronal ensembles that are important for fear memory formation in the amygdala.

Application of the RAM system to other species {#s2-7}
----------------------------------------------

One major advantage of the RAM system is its applicability to model organisms other than the mouse. We therefore tested our AAV-RAM system and P~RAM~ in rats and flies, respectively. AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP was injected into the infragranular layers (V and VI) of the rat medial prefrontal cortex (mPFC) and animals were placed on Dox ([Figure 6a--b](#fig6){ref-type="fig"}). Five days after injection, rats were taken off Dox for four days before being subjected to the inescapable stress (IS) paradigm, which is known to engage the mPFC ([@bib61]). A significantly higher percentage of RAM+ labeling was observed in animals subjected to IS compared to HC controls ([Figure 6c--d](#fig6){ref-type="fig"}). These results indicate that the RAM system can be used successfully in species other than mouse, and also in an additional brain region (the mPFC).10.7554/eLife.13918.017Figure 6.The RAM system in rats and flies.(**a**--**d**) RAM labels active neuronal ensembles in rats exposed to inescapable stress (IS). (**a**) Schematic timeline of the experimental procedure. Rats were injected with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP vectors in the medial prefrontal cortex (mPFC). After 10 days they were either subjected to IS or left undisturbed in their home cages (HC). (**b**) Schematic drawing of the rat brain with the red region indicating the target area (PL: prelimbic cortex of the mPFC) for virus infection and quantification of RAM+ cells. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the prelimbic cortex in HC and IS animals. Data are mean ± SEM, n = 3--4 animals per group, Student's t-test, \*\*p\<0.01. (**d**) Representative images of prefrontal cortex showing mKate2 (red) and EGFP (green) fluorescence in rats subjected to IS or HC conditions. Areas in purple squares are enlarged in the right image for each condition. CC: corpus callosum. Scale bars are 500 and 100 μm for the left and right images, respectively. (**e**--**h**) The *Drosophila* RAM reporter system. (**e**) Schematic diagram of the *Drosophila* RAM reporter system. The RAM-luc transgene can be turned on in specific cell types by the targeted expression of Flp recombinase using the GAL4-UAS system (left) or a cell-type specific driver (right). (**f**) *Drosophila* RAM reporter activity has low baseline levels and high fold induction. The specificity of the RAM-luc to Flp recombinase was tested using a UAS-Gal4 system, in which Flp recombinase expression is under the control of a heat-shock HS promoter. Flies in the no heat-shock (No HS) condition were maintained at 20°C throughout development and experimental conditions. For the heat-shock (HS) condition, flies were exposed to a 37°C heat shock for 30 min and allowed to recover for a full day at 20°C before measuring reporter expression. To ensure that results were not due to insertional effects, the UAS-flp transgene was combined with fly lines with the reporter transgene on either chromosome II (RAM-luc;UAS-flp) or chromosome III (UAS-flp;RAM-luc). n = 40--47 flies per group, Student's t-test, \*\*\*p\<0.001. (**g**) Pan-neuronal RAM-luc reporter expression displays circadian rhythm. The RAM-luc reporter transgene was combined with a transgene expressing FLP recombinase in all adult neurons and luciferase activity measured in live flies over time. Bars under plots indicate day (light) and night (dark). (**h**) Pan-neuronal RAM-luc reporter expression is sensitive to memory formation in *Drosophila*. Flies as described in **g** were trained in an olfactory memory task. 24 hr after training, flies exposed to Forward Spaced (FS) training showed significantly higher RAM-luc expression than control flies exposed to Backward Spaced (BS) training. Bars under plots indicate day (light) and night (dark). n = 23--24 flies per group, Student's t-test, \*\*p\<0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.017](10.7554/eLife.13918.017)

Since *Drosophila* contains both *Fos*− and *Npas4*-like transcription factors ([@bib43]; [@bib23]), we tested P~RAM~ in flies using a strategy that has been successfully implemented for CRE-based reporters ([@bib64]; [@bib59]). We generated a transgenic P~RAM~-luciferase (RAM-luc) reporter fly in which luciferase expression is tightly controlled by both the P~RAM~ promoter and FLP-recombinase ([Figure 6e--f](#fig6){ref-type="fig"}, and see 'Methods'). To test RAM-luc expression and its dependence on neuronal activity, the RAM-luc reporter transgene was combined with a transgene expressing Flp recombinase in all adult neurons (using the pan-neuronal 232B GAL4 driver). Luciferase activity measured in live flies over time showed high expression in the adult *Drosophila* brain. Most importantly, RAM-luc reporter activity was circadian ([Figure 6g](#fig6){ref-type="fig"}), suggesting that P~RAM~ functions as a robust activity-dependent promoter in *Drosophila*.

To assess whether learning experience can alter RAM-luc activity, pan-neuronal RAM-luc flies were trained in an olfactory memory task (Forward Spaced, or FS, training, in which an odor was paired with shock presentation) that is known to produce robust long-term memory that lasts up to a week ([@bib64]). Two days after training, RAM-luc activity in FS-trained flies was significantly higher than in those in the control group exposed to un-paired odor and shock presentation (Backward Spaced, or BS, training; [Figure 6h](#fig6){ref-type="fig"}). Although further work is needed to completely validate the RAM-luc reporter fly in behavioral studies, these results suggest that it can be used to identify memory-specific cellular populations in *Drosophila*.

Application of the RAM system to other cell types and Cre-dependent RAM {#s2-8}
-----------------------------------------------------------------------

We next examined the ability of our RAM system to specifically label cell types other than principal neurons that are transcriptionally induced by experience. We first sought to confirm that the RAM system works well in GABAergic neurons, which was implied by RAM labeling of neurons in CeA ([Figure 5g--i](#fig5){ref-type="fig"}), a region comprised of 95% GABAergic neurons. We injected rats with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into mPFC and subjected the animals to the IS paradigm ([Figure 7a--b](#fig7){ref-type="fig"}). Indeed, we found that the number of GAD67-labeled GABAergic neurons that were RAM+ was significantly higher in animals subjected to IS than the HC controls ([Figure 7c--d](#fig7){ref-type="fig"}). A small fraction of these induced RAM+ GABAergic neurons were parvalbumin-expressing (PV+) interneurons ([Figure 7---figure supplement 1a--d](#fig7s1){ref-type="fig"}). In mice, CFC treatment resulted in RAM labeling in a substantial number of somatostatin-positive GABAergic neurons in the hilus of the DG ([Figure 7---figure supplement 2a--f](#fig7s2){ref-type="fig"}). Additionally, using the Cre-dependent FLEX system and luciferase assay, we confirmed that P~RAM~ was induced by KCl stimulation in cultured cortical neurons derived from Gad2-Cre mice wherein Cre is expressed exclusively in neurons expressing the GABAergic neuron marker Gad65 ([Figure 7e--g](#fig7){ref-type="fig"}). These results confirm that the RAM system achieves robust activity-dependent labeling of GABAergic neurons.10.7554/eLife.13918.018Figure 7.RAM labeling of transcriptionally active interneurons and application of Cre-dependent RAM (CRAM).(**a**--**d**) RAM labels active GAD67+ neurons in rats exposed to inescapable stress (IS). (**a**) Schematic timeline of the experimental procedure. Rats were injected with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP in the mPFC. After 10 days they were either subjected to IS or left undisturbed in their home cage (HC). (**b**) Schematic drawing of the rat brain with the red region indicating the target area (PL: prelimbic cortex of the mPFC) for viral infection and quantification of RAM+ cells. (**c**) Representative images of prefrontal cortex showing EGFP (green), mKate2 (red) and GAD67 (blue) fluorescence in rats subjected to IS or HC conditions. White arrows indicate RAM+ and GAD67+ double-labeled cells. The scale bar is 100 μm and applies to all images. (**d**) Percentage of RAM+ cells co-labeled with GAD67+ in the prelimbic cortex of HC and IS animals. Data are mean ± SEM, n = 3--4 animals per group, Student's t-test. (**e**--**g**) Neuronal activity-dependence of the P~RAM~ promoter in GABAergic neurons. (**e**) Design of AAV vectors used for luciferase assays in dissociated neuronal cultures from Gad2-Cre transgenic mice. The reading frames of luciferase (luc2p) and renilla are double inverted and flanked by double loxP sites (FLEX) and inserted downstream of the P~RAM~ and thymidine kinase promoter (P~TK~) respectively. (**f**) Relative luciferase activity of P~RAM~ in Gad2-Cre cells following KCl stimulation, with application of Nimodipine and/or APV. n = 3 separate experiments per condition, one-way ANOVA, Tukey's post-hoc test. (**g**) Relative luciferase activity of P~RAM~ in Gad2-Cre cells after application of various neurotrophic factors and drugs. n = 3 separate experiments per condition, Student's t-test. (**h**) Schematic diagram of the AAV-CRAM construct. The effector gene is flanked by double loxP sites (FLEX). (**i**--**l**) CRAM labels IS-activated mPFC neurons projecting to the dorsomedial striatum (DMS). (**i**) Experimental procedure. Rats were injected with CAV2-Cre in the DMS and AAV-CRAM-tdT in the PL (**j**), then either subjected to IS or left undisturbed in their home cages (HC). (**k**) Number of CRAM+ cells in the prelimbic cortex of HC and IS animals. Data are mean ± SEM, n = 2 animals per group. (**l**) Representative images of the prefrontal cortex showing tdT fluorescence in rats subjected to IS or HC. Areas in purple squares are enlarged in the lower images. CC: corpus callosum. Scale bars are 500 and 100 μm for the upper and lower images, respectively. Data in **d**, **f**, **g** and **k** are mean ± SEM. \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.018](10.7554/eLife.13918.018)10.7554/eLife.13918.019Figure 7---figure supplement 1.RAM labeling of transcriptionally active parvalbumin (PV) cells after inescapable stress (IS).(**a**) Schematic timeline of the experimental procedure. Rats were injected with AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP vectors in the mPFC. After 10 days they were either subjected to IS or left undisturbed in their home cage (HC). (**b**) Schematic drawing of the rat brain with the red region indicating the target area (PL: prelimbic cortex of the mPFC) for virus infection and quantification of RAM+. (**c**) Percentage of RAM+ cells co-labeled with PV+ in the prelimbic cortex in HC and IS animals. Data are mean ± SEM, n = 3--4 animals per group, Student's t-test, \*p\<0.05. (**d**) Representative images of prefrontal cortex showing EGFP (green), mKate2 (red) and PV (blue) fluorescence in rats subjected to IS or HC conditions. White arrow shows a RAM+ and PV+ double-labeled cell. The scale bar is 100 μm and applies to all images.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.019](10.7554/eLife.13918.019)10.7554/eLife.13918.020Figure 7---figure supplement 2.RAM labeling in the DG hilus.(**a**) Schematic timeline of the experimental procedure. Following injection of AAV-RAM-NLS-mKate2 and AAV-Ef1α-EGFP into DG, animals were left on Dox diet (+Dox) for at least 7 days. Dox diet was withdrawn (-Dox) 48 hr before CFC and animals were sacrificed 24 hr afterwards. A control cohort of animals was left undisturbed in their home cages (HC) and received the same Dox treatment. (**b**) Schematic diagram of the hippocampus showing the targeted viral injection site (blue). RAM+ and EGFP+ double-labeled cells located exclusively in the hilus of the DG (red area) are quantified in panel **c**. (**c**) Percentage of RAM+ cells among total EGFP+ cells in the DG hilus for HC and CFC conditions. Data are mean ± SEM. n = 4 animals per condition, Student's t-test*, n.s.*, non-significant. (**d**) Percentage of RAM+ cells in the DG hilus region that are mossy cells (GluR2/3+, 49 out of 86 cells) and somatostatin positive (SST+, 101 out of 254 cells) after CFC. n = 3 animals per condition. (**e**) Representative image of RAM+/GluR2/3+ cells (indicated by arrows) in the DG hilus after CFC. The scale bar is 50 μm. (**f**) Representative image of RAM+/SST+ cells (indicated by arrows) in the DG hilus after CFC. The scale bar is 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.020](10.7554/eLife.13918.020)10.7554/eLife.13918.021Figure 7---figure supplement 3.Validation of the AAV-CRAM system.(**a**) CRAM-tdT and Ef1α-EGFP viruses were injected into wild-type or Gad2-Cre animals, and after at least 7 days kainic acid treatment was given to induce seizures. Dox was not administered throughout the experiment. (**b**) Schematic drawing of the hippocampus with the injection site (DG) highlighted in blue. (**c**) In wild-type animals, CRAM-labeled cells (tdT) were not detectable 24 hr after kainic acid treatment. The scale bar is 200 μm for the left image and 50 μm for the zoomed-in images on the right. (**d**) In Gad2-Cre animals, 24 hr after kainic acid treatment, CRAM labeled only GABAergic (predominately somatostatin --expressing) neurons while sparing the granule cells. The scale bar is 200 μm for the image on the top and 50 μm for the zoomed-in images on the bottom.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.021](10.7554/eLife.13918.021)10.7554/eLife.13918.022Figure 7---figure supplement 4.FOS expression in parvalbumin (PV) and somatostatin (SST) positive cells in primary visual cortex (V1) and dentate gyrus (DG) of the hippocampus.(**a**) Percentage of FOS+ cells among total PV+ and SST+ cells in the V1 region and DG for saline and seized conditions. Behavioral seizures were induced by PTZ or KA for maximal FOS expression. Data are mean ± SEM. n = 4--8 animals per condition, two-way ANOVA, Tukey's post-hoc test. (**b**, **c**) Representative images of V1 (**b**) and DG (**c**) showing FOS (green), SST (red), and PV (red) immuno-staining. The scale bar is 100 μm for all large images. For the zoomed-in images the scale bar is 50 μm for Saline and PTZ conditions in V1, and 25 μm and 50 μm for PV and SST conditions in DG, respectively. These images are enlarged from the areas marked by purple squares. Red arrows indicate FOS+ and PV+ or SST+ double-labeled cells.**DOI:** [http://dx.doi.org/10.7554/eLife.13918.022](10.7554/eLife.13918.022)

With a view to future investigation of ensembles involving specific cell types, we developed a Cre-dependent RAM (CRAM) system, in which the effector gene can only be expressed in cells that express Cre ([Figure 7h](#fig7){ref-type="fig"}). When CRAM-tdT virus was injected into the DG of Gad2-Cre mice, only GABAergic neurons (most prominently somatostatin-expressing neurons in the hilus) and none of the glutamatergic granule cells were labeled with tdT after kainic acid-induced seizure ([Figure 7---figure supplement 3a--d](#fig7s3){ref-type="fig"}). While IEGs are known to be induced by experience in GABAergic neurons ([@bib57]), active ensembles of GABAergic neurons have not been explored. Using Cre driver mouse lines for various types of neurons, we envision the CRAM system as a tool well suited to investigating active ensembles of GABAergic neurons and other specific neuronal cell types.

Like the RAM system, CRAM also worked well in the rat, in this case to identify neuronal ensembles with specific anatomical connections. Since a major projection of the rat PFC is the dorsal striatum ([@bib14]), we injected a retrograde canine adenovirus that expresses Cre recombinase into the dorsomedial striatum (DMS) to deliver Cre to DMS-projecting mPFC neurons. AAV-CRAM-tdT was subsequently injected into the mPFC and the animals were subjected to IS treatment ([Figure 7i--j](#fig7){ref-type="fig"}). We observed significantly more tdT-labeled neurons in animals subjected to IS compared to HC controls ([Figure 7k--l](#fig7){ref-type="fig"}), suggesting CRAM successfully labeled IS-activated mPFC neuronal ensembles that project to the DMS.

Discussion {#s3}
==========

Here we present the RAM (Robust Activity Marking) system, which makes possible the sensitive and specific labeling and manipulation of the active ensembles of neurons associated with a designated sensory and behavioral experience. Compared to existing methods used to gain access to recently active neuronal ensembles ([@bib18]; [@bib49]; [@bib56]; [@bib11]; [@bib25]), the RAM system delivers unprecedented versatility and much improved selectivity. Additionally, the system showcases a novel, informatics-based approach to constructing small synthetic IEG-sensitive promoters. We believe that this approach could be used to generate other small yet highly sensitive promoters that, when combined with the RAM platform, would allow in vivo interrogation of specific activity-dependent genetic programs.

The most important features of a neuronal-activity reporter system are high sensitivity and selectivity, resulting from a combination of low background labeling and robust effector gene expression in the active ensemble associated with a designated experience. RAM achieves exceptionally high selectivity and sensitivity through the use of an optimized activity-dependent promoter with the highest fold induction we have observed among existing small activity-regulated promoters, paired with an improved version of the Tet-Off system. In vivo RAM achieved 37-fold and five-fold increases in labeling after CFC, compared to HC controls, in CA3 and DG, respectively. This is significantly greater than the two--three-fold induction achieved using existing technologies ([@bib18]; [@bib48]). The five--37-fold induction achieved with the RAM system implies that 80--97% of the labeled neurons are truly associated with the specific experience, compared to 50--67% with existing technologies, representing a dramatic improvement in signal-to-noise ratio. This improvement alone means that the RAM system can be used in many brain regions and behavioral applications where existing methods will not work.

With its high sensitivity and selectivity, the RAM system will be ideal for functional perturbation experiments in which the activity of ensemble neurons, identified by RAM, can be manipulated through the targeted expression of effector molecules such as opsins. We show the expression of opsins in CFC-induced, RAM-labeled ensemble neurons can be activated or inhibited 24 hr after CFC ([Figure 3---figure supplement 4a--j](#fig3s4){ref-type="fig"}), demonstrating the feasibility of such an approach using RAM. Based on the robust results we obtained by applying RAM to label ensembles in several brain regions (DG, CA3, amygdala and mPFC) using appropriate behavioral paradigms (CFC, TFC and IS), we anticipate that RAM can be readily used to investigate neuronal ensembles in other brain regions, such as CA1, striatum, nucleus accumbens, hypothalamus, etc., for a variety of behavioral manipulations in the future.

Like all other existing activity reporters currently being used in the neuroscience field, the sensitivity of the RAM system has not been systematically measured. For example, we do not know the activation threshold for RAM. More specifically, what is the minimal amount of neuronal activity required to activate RAM? What type of neuronal activity is preferentially captured by RAM? How well can RAM distinguish information-carrying neuronal firing from fluctuating noise? Future experiments aimed to obtain these basic operational parameters for RAM, and for any activity reporter, will be critical for us to be able to use these reporters to gain mechanistic understanding of how sensory and behavioral information is processed in the brain.

As for any IEG-based activity reporter, the efficiency of RAM labeling in particular brain regions or of particular cell types depends on their propensity to express IEGs. For example, activated PV+ neurons appear to be less likely to express IEGs. Even after pentylenetetrazol (PTZ)-induced seizure, only about 20% of the PV+ neurons, compared to over 80% of somatostatin expressing (SST+) neurons, in the cortex were transcriptionally activated to express FOS ([Figure 7---figure supplement 4a--b](#fig7s4){ref-type="fig"}). A similar trend was observed in DG after KA-induced seizure ([Figure 7---figure supplement 4a, c](#fig7s4){ref-type="fig"}), suggesting either PV+ neurons may be less likely to be recruited to active ensembles or they may require non-IEG-based approaches to be effectively labeled.

The compact design of the RAM system allows it to be packaged into a single AAV while still accommodating an effector gene up to 1.8 Kb in size. The RAM system can readily accommodate most of the effector genes commonly used to label or manipulate neural circuits. We envision future experiments using effector genes for genetic profiling (e.g. RIBO-TRAP \[[@bib53]\]), rabies-mediated monosynaptic anatomical tracing ([@bib5]), and functional perturbation of behavior ([@bib35]) (see [Figure 3---figure supplement 4e,j](#fig3s4){ref-type="fig"}). In cases where other, larger promoters and/or larger effector genes are needed, the RAM system can split between two AAVs, one containing the d2tTA expression cassette and the other the TRE-effector cassette.

Cre-dependent RAM (CRAM) extends the versatility of the RAM system even further. For example, CRAM can be used to study active neuronal ensembles of a particular cell type when Cre expression is controlled by a cell type-specific promoter in a mouse line or virus. Also, by delivering Cre via retrograde and anterograde viruses, neuronal ensembles with specific anatomical connectivities can be explored. Finally, a Flp-dependent RAM system could easily be developed, allowing additional applications of the system.

Since the P~RAM~ 10mer is highly enriched in activity-dependent enhancers ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) and enhancers are mostly conserved between species ([@bib28]), P~RAM~ is likely to be active in many different species. Here we demonstrate that P~RAM~ works in mice, rats and flies, but it may be applicable to other species as well. Given the flexible design of the RAM system and the relative ease of AAV production, the system makes possible many new and powerful experiments in a field with relatively few viable tools ([@bib7]; [@bib26]).

Methods {#s4}
=======

Screening for enriched enhancer {#s4-1}
-------------------------------

The coordinates on the mouse chromosome mm9 assembly for the 11,830 activity regulated enhancers identified by [@bib28] were downloaded and the sequences from a 2 Kb window centered at each enhancer were extracted. We first looked for DNA elements enriched among activity-regulated enhancers. Sequences in a 160 bp window centered on each enhancer were extracted and then used as inputs for the *de novo* motif finding software Weeder ([@bib42]) (<http://159.149.160.51/modtools/>). The top motif identified strongly resembles the consensus for AP-1 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

To calculate the enrichment of all AP-1-containing 10mers (128 in total, see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}), we searched for perfect matches on both strands for each 10mer and counted the number of hits on each 40 bp non-overlapping bin. Enrichment for each 10mer was calculated as the total number of occurrences in the four central bins (i.e. the −80 to +80 region) divided by the total number of occurrences in the eight furthest bins on each flank (−1000 to −681 and +681 to +1000). The larger flanking regions were used to obtain a more accurate estimate of the fold enrichment at the enhancer center relative to the flanks. The enrichment factor, E, adjusted for the larger size of the flanking bins, was defined as E = 4\*C/F, where C is the number of hits in the central bins and F is the number of hits in the flanks. The significance of finding each motif was calculated using a binomial test (in MATLAB) under the null hypothesis that the hits should be equally distributed between the center and flanks. The p-value is given by p=1-CDF (4\*C, 4\*C + F, 0.5), where CDF (n, N, 0.5) is the cumulative distribution function of finding n elements from a binomial distribution with parameters N and 0.5. If there were no hits in either the center bins or the flanks, the p-value was set to 0.5, and the motif was not considered further. The motifs were ranked by their enrichment factors. Motifs that did not have a Bonferroni corrected p-value\<0.05 were excluded from further analysis. A full list of 10mers containing the AP-1 consensus site, ranked by their enrichment factors, can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Several enriched 10mers (E1-E3) were selected to construct synthetic promoters for further testing based on their enrichment factor and the associated p-value.

Cloning of plasmids {#s4-2}
-------------------

All luciferase-encoding plasmids were based on the pGL4.11 backbone (luc2p, Promega, Madison, WI). Complementary strands of enhancer modules (EM), P~NRE+AP1~, P~RAM,~ enriched 10mer-containing enhancer module variants (E1-E3) and CME sequences, each containing four identical repeats, were ordered as DNA oligos (Sigma Aldrich, Natick, MA) with the following sequences and annealed:

P~NRE+AP-1~: 5'-- CT**[TCGTG]{.ul}**ACTAGTCT**[TGACTCA]{.ul}**GA --3'

P~RAM~: 5'-- CTAGAAGTTTGT**[TCGTGACTCA]{.ul}**GA --3'

E1: 5'-- CTAGAAGTTTGT**[TGACTCACCC]{.ul}**GA --3'

E2: 5'-- CTAGAAGTTTGT**[TGACTCATTA]{.ul}**GA --3'

E3: 5'-- CTAGAAGTTTGT**[GTATGACTCA]{.ul}**GA --3'

CME: 5'-- CTAGAAATTTGT**[ACGTGCCACA]{.ul}**GA --3'

Nucleotides underlined (in bold) denote putative binding motif and/or variable flanking regions. One annealed P~RAM~ EM served as a template for making various enhancer repeats (1, 2, 3, 4 and 8 enhancer repeats) by In-Fusion cloning (Clontech). The minimal promoters were PCR cloned from other constructs: the *FOS* minimal promoter (99 bp) from pOF-luc plasmid ([@bib54]); the *Arc* minimal promoter (421 bp) from ESARE plasmid, a gift kindly provided by Haruhiko Bito ([@bib25]); the human beta-globin (hBG) minimal promoter (49 bp, a gift kindly provided by Guoping Feng), the cytomegalovirus (CMV) minimal promoter (226 bp) from pcDNA3 plasmid (Invitrogen). Annealed enhancers were inserted upstream of the minimal promoter(s) and then inserted into pGL4.11 using Kpn1 and Nhe1 sites.

Other activity-dependent promoters, inserted into pGL4.11 to drive luciferase expression, were derived from other studies: *Npas4* ([@bib47]), p1BDNF ([@bib47]), ESARE (kindly provided by Haruhiko Bito \[[@bib25]\]), *Fos* ([@bib2]), CREB reporter from CRE-luc2p (Promega), and MEF2 reporter ([@bib54]). Overexpression plasmids encoding *Npas4* and *Fos* were constructed by PCR cloning as follows: the coding regions of *Npas4* and *Fos* were inserted into the pEF1/*myc*-His (A) backbone (Life Technologies, Carlsbad, CA) using Spe1 and Pme1 sites. The empty pEF1/*myc*-His (A) backbone served as a transfection control.

Vectors used to engineer and characterize the RAM driven Tet-OFF system were derived from pTet-Off-Advanced and pTRE-Tight vectors (Clontech, Mountain View, CA). The CMV promoter in pTet-Off-Advanced was replaced by inserting P~RAM~ within the Spe1 and Sac1 sites (P~RAM~-tTA). Decreased stability tTA was made by fusing the degradation domain of mouse ornithine decarboxylase (MODC, derived from pD2EGFP; Clontech) to the N-terminus of tTA, making P~RAM~-d2tTA. The MODC contains a PEST sequence that enhances tTA degradation ([@bib33]). Transferring luciferase (luc2p) from pGL4.11 into pTRE-Tight using HindIII and Xba1 sites resulted in the TRE luciferase (pTRE-luc2p) vector.

Glia cultures and neuron-glia co-cultures {#s4-3}
-----------------------------------------

Preparation of cultures with a confluent glial monolayer has been described elsewhere ([@bib40]). Briefly, astrocytes derived from P1-P2 rat cortices were plated at low density in DMEM + 10% FBS on 12 mm glass coverslips coated with poly-D-lysine and laminin in 24-well plates, and stored and maintained at 37°C in a humidified incubator with 10% CO~2~. Once the plated glia cells had formed a confluent monolayer, typically after 7 days, dissociated hippocampal neurons from mouse P1 pups (C57Bl/6, Charles River Laboratory) were plated at a density of 40,000 cells per well, and the media was changed to NBA supplemented with B27 (Invitrogen, Carlsbad, CA) and GlutaMAX (Life Technologies). AraC (5 μM, Sigma) was added the next day and conditioned media was supplemented with fresh media every fifth day. Pure glia cultures were used for a set of luciferase experiments, whereas neuron-glia co-cultures were used for immunocytochemistry (ICC) experiments. For ICC experiments, cultures were stimulated with bicuculline (50 μM, Sigma Aldrich) and 4AP (250 μM, Tocris, UK), and doxycycline was applied at 40 ng/mL final concentration.

Immunocytochemistry {#s4-4}
-------------------

Cultures were washed once with PBS (pH 7.4), then fixed for 10 min with 4% paraformaldehyde in PBS containing 0.1% Triton X-100. Subsequently, cultures were washed 3 times with 10 mM glycine in PBS followed by a final rinse with PBS. The primary antibody was added to a solution of 0.1% porcine gelatin (Sigma), 0.25% Triton X-100, 0.23 M NaCl, and 0.015 M phosphate buffer pH 7.4, and coverslips were then transferred to a humidifying chamber. Antibody solution was dropped (50 μL) onto each coverslip and allowed to incubate at 4°C overnight. The next day, the coverslips were washed 4 times with PBS, and incubated in 50 μL of secondary antibody solution for 1 hr at room temperature. Coverslips were washed twice with PBS and mounted on Superfrost slides using DAPI Flouromount-G (SouthernBiotech, Birmingham, AL) before imaging and analysis. The primary antibodies were MAP2 (mouse, 1:1000, Sigma, M9942) and GFAP (mouse, 1:1000 Sigma, G3893). The secondary antibody was Alexa Fluor 488 (Goat anti-mouse IgG, 1:1000, Life Technologies).

Cell cultures for luciferase assays {#s4-5}
-----------------------------------

Mouse pups, C57Bl/6 (Charles River Laboratory) or Gad2-Cre (*Gad2^tm2(cre)Zjh^/J*, Jackson Laboratory), at P1 were used to prepare dissociated hippocampal cultures as previously described ([@bib34]). Cultures were plated at 100,000 cells per well on 24-well plates coated with poly-D-lysine. Cultures were incubated in Neurobasal A Medium (NBA, Life Technologies) with horse serum and glutamine added. The cultures were maintained at 37°C in a humidified incubator with 5% CO~2~. After three hours of incubation, the medium was changed to NBA supplemented with B27 (Invitrogen) and GlutaMAX (Life Technologies). Neurons were transfected using lipofectamine 2000 (Life Technologies) on DIV5. Reporter plasmids (in pGL4.11) expressing firefly luciferase and a plasmid expressing renilla luciferase under control of the constitutive thymidine kinase promoter (TK)-Renilla (Promega) were co-transfected in every experiment. For a subset of luciferase experiments, cultures were co-infected with AAV vectors (0.1 μL per well) expressing firefly luciferase and TK-Renilla, respectively.

On the day of stimulation, TTX and APV were typically added 1 hr prior to stimulation, and cells were stimulated for 6 hr with 35 mM KCl (but see [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} for precise details) before being rinsed briefly in PBS and lysed in passive lysis buffer (Promega). The Dual-Glo Luciferase Assay System reagents were used according to the manufacturer's instructions (Promega). Firefly luciferase levels were measured and expressed relative to renilla luciferase levels. Data were compiled from separate experiments each conducted in triplicate, and repeated a minimum of three times. Fold induction of luciferase was calculated as the ratio between stimulated and unstimulated conditions.

The primary criterion we used to evaluate the synthetic promoters for use as neuronal activity reporters was the fold change in luciferase expression. This is the ratio of the relative luciferase values between stimulated and unstimulated conditions and represents the activity-dependence and selectivity of the promoter. A secondary criterion was the absolute expression level after stimulation, which is the absolute luciferase value normalized against an internal control and reflects the absolute transcriptional strength of the promoter. It is possible for a weak promoter to have high fold induction, due to extremely low activity under basal unstimulated conditions, but to only drive transcription modestly, which will limit its ability to drive the expression of an effector gene to sufficient levels to achieve the required effects.

Drugs and neurotrophic factors, typically applied together with 10 μL NBA into the wells, were used at the following final concentrations: TTX (1 μM, Tocris), APV (100 μM, Tocris), Nimodipine (5 μM, Tocris), Bicuculline (50 μM, Sigma Aldrich), 4AP (250 μM, Tocris), recombinant human BDNF (50 ng/μL, PeproTech, Rocky Hill, NJ), recombinant human NT3 (50 ng/μL, PeproTech), recombinant human NT4 (50 ng/μL, PeproTech), recombinant human IGF1 (50 ng/μL, PeproTech), recombinant human EGF (50 ng/μL, PeproTech), Forskolin (10 μM, Tocris) and PMA (100 ng/μL, Tocris).

Construction of RAM viral vector {#s4-6}
--------------------------------

The AAV vector V032 (pFB-AAV-CMV-WPRE-SV40pA, kindly provided by Rachael Neve) served as the backbone for constructing the AAV-RAM vector. All components within the 5'-ITR and 3'-ITR defined by the Mlu1 and Kpn1 sites, respectively, were first removed from V032. At the 5'-ITR site, the TRE promoter followed by a multiple cloning site (MCS), WPRE and bGH poly(A) signal was inserted as one expression cassette in the 5' to 3' direction. In the same orientation, the second expression cassette, consisting of P~RAM~ driving d2tTA followed by a SV40 poly(A) signal, was inserted downstream of the first cassette and terminated by the 3'-ITR. The two expression cassettes were insulated by incorporation of synthetic poly(A) and RNA polymerase II transcriptional pause signals (both derived from pGL4.11) between the two cassettes. Fluorescent proteins, including tdTomato and mKate2, and the two opsins, Channelrhodopsin (ChR2, a kind gift from Gloria Choi) and Archaerhodopsin (ArchT, a kind gift from Ed Boyden), were inserted into the MCS. The plasmids AAV-RAM and AAV-CRAM vectors (as depicted in [Figure 1f](#fig1){ref-type="fig"}, pAAV-RAM-d~2~TTA-pA::TRE-MCS-WPRE-pA; and [Figure 7h](#fig7){ref-type="fig"}, pAAV-RAM-d~2~TTA-pA::TRE-FLEX-MCS-WPRE-pA) with an empty MCS at the effector gene position have been deposited at Addgene. The transfection control plasmid, pAAV-Ef1α-EGFP-WPRE-pA, was made by replacing mVenus in pAAV-Ef1α-mVenus-WPRE-pA (kindly provided by Jonathan Ting) using BamHI and BsrGI sites.

Viruses and viral production {#s4-7}
----------------------------

For ICC, we used AAV-RAM-tdTomato (AAV-RAM-d2tTA-pA::TRE-TdTomato-WPRE-pA, AAV8 serotype, Virovek, Hayward, CA, 2.21E13 vg/mL). For rat studies, we used AAV-RAM-NLS-mKate2 (AAV-RAM-d2tTA-pA::TRE-NLS-mKate2-WPRE-pA, AAV1 serotype, Virovek, 2.18E13 vg/mL) and transfection control AAV-Ef1α-EGFP (AAV-Ef1α-EGFP-WPRE-pA, AAV1 serotype, UPenn Vector Core, 5.51E13 vg/mL). We also generated homemade AAVs using a FuGene6 (Promega) mediated triple plasmid co-transfection method in HEK293t cells. Three days after transfection, cells were harvested and virus was purified using an adapted Iodixanol gradient purification protocol ([@bib37]). These AAVs were a mixture of AAV2/2 (rep/cap) and AAV2/8 serotypes at a 1:1 ratio. Additionally, our AAV2/2 capsid incorporated three mutations (Y444F, Y500F and Y730F) ([@bib39]) while our AAV2/8 capsid had a double mutation (Y447F and Y733F) ([@bib45]). To determine the properties of AAV-RAM expression and for quantification of behaviorally labeled cells and IEG overlap experiments in vivo, we used homemade AAV-RAM-mKate2 (AAV-RAM-d2tTA-pA::TRE-NLS-mKate2-WPRE-pA, mixed AAV2/8 serotype, 1.28E13 vg/mL) and transfection control AAV-Ef1α-EGFP (AAV-Ef1α-EGFP-WPRE-pA, mixed AAV2/8 serotype, 2.07E13 vg/mL) vectors. These were applied together at a 1:1 ratio and diluted 10 times in DPBS before use. For the RAM-ChR2 and RAM-ArchT experiments, we used homemade AAV-RAM-ChR2:EYFP (AAV-RAM-d2TTA-pA::TRE-ChR2:EYFP-WPRE-pA, serotype 9, 4.33E13 vg/mL), AAV-RAM-ArchT:EGFP (AAV-RAM-d2TTA-pA::TRE-ArchT:EGFP-WPRE-pA, serotype 9, 2.19E13 vg/mL) and AAV-TRE-mCherry (AAV-TRE-mCherry-pA, serotype 9, 2.24E13 vg/mL). For a subset of luciferase experiments, we produced AAV viruses (mixed AAV2/8 serotype) of pAAV-TK-FLEX-Renilla-WPRE-pA (7.36E12 vg/mL) and pAAV-RAM-FLEX-luc2p-WPRE-pA (5.13E12 vg/mL). Both these constructs were cloned in our laboratory. For Cre-dependent RAM (CRAM) expression, we produced AAV-CRAM-tdTomato virus (AAV-RAM-d2TTA::TRE-FLEX-tdTomato-WPREpA, serotype 2/8, 1.22E13 vg/mL). Canine adenovirus serotype 2 (CAV2) ([@bib22]) was engineered to express Cre recombinase, CAV2-Cre (10.3E12 pp/mL; kindly provided by Dr. Eric J. Kremer). Genomic AAV titer was determined by a PicoGreen-based method as described elsewhere ([@bib44]). Before use, all viruses were carefully examined in pilot experiments and, if needed, diluted in DPBS for optimized titer.

Mouse subjects {#s4-8}
--------------

Adult male C57Bl/6 mice (Charles River Laboratory) were 7--10 weeks of age for all surgeries and behavioral manipulations. Gad2-Cre (*Gad2^tm2(cre)Zjh^/J*, Jackson Laboratory) mice were used for CRAM experiments. Following stereotaxic viral vector injections mice were single-housed for 7--14 days. All mice were housed in a temperature-controlled facility with a 12 hr light/dark schedule and provided with food and water *ad libitum*. All mouse protocols were performed in accordance with NIH guidelines and approved by the Massachusetts Institute of Technology Committee on Animal Care (protocol \#1014-105-14).

Rat subjects {#s4-9}
------------

Adult male Sprague-Dawley rats (275--300 g; Harlan, Indianapolis) were pair housed in a temperature- and humidity-controlled room on a 12 hr light/dark cycle (lights on at 7:00 A.M.). Standard lab chow and water were available *ad libitum*. Rats were allowed to acclimate to colony conditions for 7--10 days prior to surgery. All rat procedures were performed in accordance with NIH standard ethical guidelines and were approved by the Institutional Animal Care and Use Committee at the University of Colorado Boulder (protocol \#1505.07).

Viral vector delivery {#s4-10}
---------------------

Mice were placed on doxycycline chow 24 hr prior to surgery (40 mg/kg, Bio-Serv, Flemington, NJ). On the day of surgery, mice were anaesthetized using isoflurane (3% induction, 1.5% maintenance during surgery) and secured to a stereotactic frame (Kopf) with a heating pad to maintain body temperature. Mice were injected sub-dermally with Buprenex (1 mg/kg) and given topical Lidocaine (20 mg/mL) for analgesia (Hi-Tech Pharmacal, Amityville, NY). Following exposure of the skull, a small craniotomy was made overlying the target brain structure. Using a glass pipette (50 µm tip) connected to a Nanoject II (Drummond Scientific, Broomall, PA) injector, AAVs were delivered (50 nL/infusion, 30 sec between infusions) to the brain, and allowed to diffuse for 10 min before withdrawing the pipette. The coordinates of the target brain structures in reference to bregma (mm) and injection volumes (nL) were as follows: dentate gyrus (AP: −1.9, ML: ± 1.4, DV: −2.05; 600), dorsal CA3 (AP: −1.9, ML: ± 1.85, DV: −2.1; 500), basolateral amygdala (AP: −1.6, ML: ± 3.25, DV: −3.6 from pial surface; 1000), and central amygdala (AP: −1.4, ML: ± 2.85, DV: −3.7 from pial surface; 300). All injections were performed bilaterally. Mice were kept on doxycycline chow and allowed to recover for 7--14 days following surgery.

Rats were anesthetized with isoflurane. A midline incision was made to expose the skull, and a small craniotomy was made unilaterally above the medial prefrontal cortex (mPFC). Recombinant AAV was injected into the prelimbic cortex (PL) of the mPFC. A stainless steel needle with the beveled tip facing laterally (31 gauge; Hamilton Company, Reno, Nevada) was directed to the PL (AP: +2.5, ML: ±0.5, DV: −2.0 from pial surface). For the CRAM experiment in rats, CAV2-Cre was bilaterally injected to the dorsal medial striatum (AP: +0.1, ML: ± 2.0, DV: −3.5 from pial surface). Virus (1.0 μL/hemisphere) was infused over 10 min (0.1 μL/min), followed by an additional 10 min to allow diffusion of the virus from the needle tip. The skin was sealed with Vetbond tissue adhesive.

Rodent behavior {#s4-11}
---------------

Doxycycline chow was typically withdrawn 48 hr prior to behavioral manipulation and replaced with regular feed, but see figure legends for precise experimental setup.

Contextual fear conditioning {#s4-12}
----------------------------

To assess behavior-specific induction of RAM in the hippocampus, we trained mice in a context-dependent classical conditioning paradigm following our previously established protocol ([@bib47]). Briefly, mice were placed in a box with salient visual cues, and allowed to explore for 58 s terminated by a 2 s, 0.55 mA foot-shock. This was repeated three times at 58 s intervals. Mice were kept in the chamber for an additional 60 s before being placed back into their home cages. Mice experiencing the conditional stimuli only (Context Only) were left for 240 s in the box, whereas mice experiencing the unconditional (Shock Only) stimuli only received the foot-shocks immediately once placed in the chamber and were then returned back to their home cage.

Tone fear conditioning {#s4-13}
----------------------

To examine behavior-specific induction of RAM in the amygdala, we utilized an associative tone-fear conditioning paradigm, once again following an established protocol ([@bib47]). Briefly, mice were placed in a chamber and allowed to acclimate for 40 s. A tone (2.5 kHz, 85 dB, 20 sec) co-terminating with a foot-shock (0.55 mA, 2 s) was presented four times at 40 s intervals. The mice were given an additional 60 s in the chamber following the final tone presentation before being placed back into their home cages. A subset of mice received the conditional (Tone) stimuli only, but was otherwise handled similarly. Mice experiencing the unconditional (Shock) stimuli only received the foot-shocks immediately once placed in the chamber and were then returned back to their home cage.

IEG overlap experiment {#s4-14}
----------------------

In order to characterize the extent of IEG protein expression in the same brain sections as RAM expressing cells, animals were run through the contextual fear conditioning paradigm (context A) listed above. The following day, mice were placed either back into the box from the original conditioning (context A) or into a novel context (context B) for 4 min and manually scored for freezing behavior every 5 s. 1.5 hr after the recall testing, animals were sacrificed and their brains were processed for immunohistochemical analysis.

Drug induced seizures {#s4-15}
---------------------

Pharmacologically induced seizures were used to drive maximal RAM or IEG expression in the hippocampus or cortex. Mice were given intraperitoneal injections of 15 mg/kg kainic acid (Sigma), pH 7.4, or 50 mg/kg pentylenetetrazole (Sigma), and were selected for further analysis only if they exhibited full motor seizures.

Inescapable stress {#s4-16}
------------------

Rats were exposed to a single session of inescapable stress (IS) in Plexiglas boxes (14 × 11 × 17 cm) with a Plexiglas rod protruding from the rear. The rat's tail was secured to the rod with tape and affixed with copper electrodes. Each session consisted of 100 trials of tail shock (5 sec duration, 33 × 1.0 mA, 33 × 1.3 mA, and 34 × 1.6 mA) on a random-interval 1 min schedule. Subjects were returned to the colony immediately following the tail shock procedure.

Immunohistochemistry {#s4-17}
--------------------

All histological analysis of RAM expression was performed 24 hr following relevant stimulus presentation. Mice and rats were deeply anesthetized with isoflourane and the brains were removed and drop-fixed in 4% paraformaldehyde in PBS. Brains were fixed for 24 hr at 4°C and then cryoprotected in 30% sucrose in PBS at 4°C until they sank. Subsequently, brains were sectioned on a cryostat at 50 µm thickness. All sections were blocked for 2 hr at room temperature in a TBS (pH 8.0) solution containing 0.5% tritonX-100, 0.2% BSA, 10% normal goat serum and then incubated with primary antibody in blocking solution, typically overnight at 4°C. The next day, sections were rinsed in PBS and incubated in secondary antibody for 2 hr at room temperature. Sections were mounted on Superfrost slides and coverslipped in DAPI Flouromount-G (SouthernBiotech). Primary antibodies used: FOS (rabbit, 1:1000, Santa Cruz sc-52), NPAS4 (rabbit, 1:10,000) ([@bib34]), Glutamate Receptor 2&3 (GLUR2/3, rabbit, 1:200, Millipore AB1506), Somatostatin (SST, rat, 1:200, Millipore MAB354), Parvalbumin (PV, mouse, 1:1000, Millipore MAB1572), α-mKate2 (tRFP antibody recognizing mKate2, rabbit, 1:200, Evrogen AB223) and GAD67 (mouse, 1:1000 or 1:500 Millipore MAB5406). Secondary antibodies used: Alexa Fluor 405 (1:500, Thermo Fisher) and Alexa Fluor 647 (goat anti-rabbit IgG, goat anti-rat IgG, or goat anti-mouse IgG, 1:1000, Life Technologies).

Image acquisition and cell quantification {#s4-18}
-----------------------------------------

For mouse brains, low magnification images were acquired from coronal sections using an Olympus BX51 fluorescent microscope using a 10X or 20X objective and MetaMorph software (Molecular Devices, Sunnyvale, CA). High magnification images were acquired from coronal sections using an Olympus Fluoview FV1000 with a 60X oil-immersion objective and Fluoview imaging software. All images were pseudo colored, merged and quantified using ImageJ software. Cell counts were performed using the Cell Counter plug-in. Briefly, all infected cells were confirmed by using the DAPI channel, and individual counts were taken for EGFP and RAM positive cells in order to provide a percentage of RAM+ cells among the infected population. Images were only taken in regions of maximum viral infectivity as determined by a near 100% neuronal expression of the EGFP infection marker. Counts were quantified from 3--5 separate sections from each injected hemisphere from 3--9 animals per condition.

For rat tissue, image acquisition was performed with a confocal system (ZeissLSM510; Carl Zeiss) using 5X and 20X objectives. Confocal images were acquired using identical pinhole, gain and laser settings. For each subject, the number of fluorescence mKate2 and tdT positive cells were quantified and averaged from 2--4 tissue sections of the PL.

IEG overlap experiment imaging and analysis {#s4-19}
-------------------------------------------

Mice were exposed to a contextual fear conditioning paradigm and were then placed back into their home cages to allow for hippocampal RAM expression. Twenty-four hours later, the mice were divided into two cohorts and were either re-exposed to the initial conditioning context, or exposed to a novel context, and were then sacrificed 1.5 hr later. Alternating 50 µm brain slices were stained for NPAS4 or FOS. Coronal sections were imaged using an Olympus Fluoview FV1000 confocal microscope with a 60X oil objective and Fluoview imaging software. Images were only taken in regions of maximum viral infectivity as mentioned previously. For each animal (n = 4--5 per condition), 7--10 images were taken of the granule cell (GC) layer of the dorsal dentate gyrus, focusing on the apex of stratum granulosum. Each image was acquired as a Z-stack 20--35 µm thick, with a step size of 2.5 µm (slice thickness = 0.884 µm). After acquisition, RAM+, IEG+ and RAM+/IEG+ cells were confirmed to be DAPI positive and were manually counted for each stack in Fluoview. Overlap was defined as the percentage of RAM+ cells that were also IEG+. We estimated the total number of GCs per image as follows. High-resolution cubes (n = 18) of 35 × 35 × 10 µm were imaged in the DAPI channel with a 1 µm step size. We estimated the diameter of each DAPI labeled GC nuclei to be 7.5 µm. For the entire cube, DAPI cells were counted, excluding those touching 3 of the 6 image faces, and the count was divided by the total cube volume to get a GC density estimate. Our overall GC density was calculated to be 1.35 ± 0.06 cells/1000 µm^3^, slightly higher than previously published estimates ([@bib9]; [@bib27]). For each slice, total DG granule cell layer area was measured in Fluoview and multiplied by the stack thickness to get a GC volume. The calculated GC density was then used to give a total GC estimate per slice.

Whole-cell patch-clamp recordings of RAM-ChR2 and RAM-ArchT cells in acute slice preparations {#s4-20}
---------------------------------------------------------------------------------------------

Mice were decapitated 24 hr following CFC. The brains were removed from the skulls and immediately immersed in carbogenated ice-cold cutting solution containing (in mM) sucrose 75, NaCl 67, NaHCO~3~ 26, glucose 25, KCl 2.5, NaH~2~PO~4~ 1.25, CaCl~2~ 0.5, MgCl~2~ 7, 310 mOsm, pH 7.35. In the same solution, 300 µm horizontal slices were cut with a vibrating blade microtome (VT1200, Leica, Germany). Slices containing the dorsal hippocampus were transferred to an incubation chamber filled with carbogenated warm (32˚C) cutting solution for 10--20 min and then at room temperature (\~23˚C) for at least 1 hr before being used. For recording, slices were transferred to a recording chamber perfused at a flow rate of 2 ml/min with artificial cerebrospinal fluid (ACSF) containing (in mM) 119 NaCl, 2.5 KCl, 1.24 NaH~2~PO~4~, 1.3 MgCl~2~, 2.5 CaCl~2~, 26 NaHCO~3~, and 10 glucose, carbogenated with 95% O~2~ and 5% CO~2~ gas mixture and kept at room temperature. Borosilicate glass pipettes (4--6 MΩ tip resistance) were used for whole-cell patch-clamp recordings and filled with internal solution as follows (in mM): 130 K-gluconate, 10 KCl, 1 MgCl~2~, 10 HEPES, 0.2 EGTA, 4 Mg-ATP, 0.5 Na-GTP, pH 7.25, 290 mOsm osmolarity.

RAM+ neurons expressing ChR2 or ArchT were recorded in a mixture of 50 µM picrotoxin, 50 µM APV and 20 µM DNQX to block fast GABAergic and glutamatergic synaptic transmission. A square pulse of −5 mV was delivered at the end of every sweep to monitor access resistance. Recordings with access resistance greater than 25 MΩ or with changes in access resistance greater than 15% were discarded. ChR2 and ArchT expressing RAM+ cells were illuminated with 455 nm blue and 565 nm green light, respectively, through a 40X optical lens, and the light sources (LEDs, Thorlabs, Newton, NJ) were controlled by the pClamp10 interface. Data were collected with a Multiclamp 700 b amplifier (Molecular Devices), Bessel filtered at 2 kHz. Data were digitized at 10 kHz using a Digidata 1440A (Molecular Devices) and were acquired using pClamp10 software. Photocurrents were measured using pClamp10.

Generation of RAM reporter fly {#s4-21}
------------------------------

Three RAM binding sites were placed upstream of a minimal promoter and CaSpeR TATAA sequence, followed by flippase recognition target (FRT)-flanked stop codons and the luciferase open reading frame. A short sequence coding for a poly-glycine run was placed downstream of the second FRT site and arranged so that it was in the same reading frame as the ATG start codon, regardless of which FRT site remained after site-specific recombination. The luciferase-coding region (minus its normal ATG start codon) was placed downstream and in frame with the poly-glycine run. In the absence of the flippase (FLP), the transgene would produce no luciferase protein. After FLP-mediated recombination, a fusion protein would be expressed that contains amino acids from the FRT sequence and a poly-glycine run, all fused to luciferase. Reporter constructs were inserted at the NotI/XhoI sites of pCaSper5. Standard methods were used to generate transgenic flies (BestGene). The specificity of the RAM-luc to Flp recombinase was tested using a UAS-Gal4 system, in which Flp recombinase expression is under the control of a heat-shock (hs) promoter (see [Figure 6e--f](#fig6){ref-type="fig"}).

Fly behavioral training {#s4-22}
-----------------------

Flies were trained in the olfactory avoidance-training paradigm developed by Tully and Quinn and modified to allow for automated training sessions ([@bib13]). A single cycle of training consists of 90 s exposure to ambient air; 60 s of electric shock (the unconditioned stimulus); 70 olt pulses lasting 1.5 s and administered every 5 s (12 total) accompanied by simultaneous exposure to 1 odor (the conditioned stimulus condition, CS**+**); 45 sec of ambient air exposure to clear the first odor; 60 s of exposure to the second odor, with no shock (the CS**-** condition), 45 s of ambient air to clear the second odor. Spaced training consists of ten single cycles separated by 15 min rest intervals. We used 3-octanol and 4-methylcyclohexanol as odors. One group of flies was exposed to Forward Spaced (FS) training, where the odor was paired with shock presentation. The control group of files was exposed to the same number of training trials, but the non-overlapping odor and shock presentations did not overlap in time (Backward Spaced, or BS training), which does not produce associative memory.

In vivo luciferase assays in flies {#s4-23}
----------------------------------

Flies were housed at 50 flies per vial and entrained on a 12 hr light/dark cycle for 3--5 days before beginning experiments. 24 to 48 flies were loaded into a black 96-well microplate containing luciferin media: 1% agar, 5% sucrose, 5 mM D-Luciferin (Gold BioTechnology, Olivette, MO). Plates were maintained at 22°C under controlled light conditions and cycled approximately once per hour through a Packard TopCount Scintillation and Luminescence counter. To display oscillatory activity of pan-neuronal RAM-luc reporter ([Figure 6g](#fig6){ref-type="fig"}), a smoothing function was applied such that each data point represented the average of three measurements. To compare overall activity between groups ([Figure 6h](#fig6){ref-type="fig"}), the mean hourly reading was calculated for each fly and compared.

Statistics {#s4-24}
----------

All statistical information is provided in the figure legends and [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}. Data obtained from the 10mer screen were analyzed using a binomial test (see 'Screening for Enriched Enhancer*'* for details). All other data were compiled and analyzed using GraphPad Prism 5.0 software. Unpaired Student's t-test, one-way ANOVA with Tukey or Dunnet post-hoc test, and two-way ANOVA with Bonferroni post-hoc test were used whenever appropriate. The level of significance was set at p\<0.05. All data are presented as mean ± SEM. No estimates of power were performed before experiments, but sample size numbers were similar to those generally employed in the field.
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###### A full list of AP-1 containing 10mers (128 in total) ranked by their enrichment factor.

See 'Methods' for further details. 10mers used in P~RAM~ and enhancer elements E1-E3 ([Figure 1a](#fig1){ref-type="fig"}, and [Figure 1---figure supplement 2b](#fig1s2){ref-type="fig"}) are highlighted in bold. 10mers with corrected p-value≥0.05 are marked in grey color.

**DOI:** [http://dx.doi.org/10.7554/eLife.13918.023](10.7554/eLife.13918.023)

10.7554/eLife.13918.024

###### Experimental conditions and statistics.

**DOI:** [http://dx.doi.org/10.7554/eLife.13918.024](10.7554/eLife.13918.024)

Major datasets {#s7}
--------------

The following previously published dataset was used:

Kim TK,Hemberg M,Gray JM,Costa AM,Bear DM,Wu J,Harmin DA,Laptewicz M,Barbara-Haley K,Kuersten S,Markenscoff-Papadimitriou E,Kuhl D,Bito H,Worley PF,Kreiman G,Greenberg ME,2010,Widespread transcription at neuronal activity-regulated enhancers,<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21161>,Publicly available at the NCBI Gene Expression Omnibus (accession no. GSE21161)
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Decision letter

Nathans

Jeremy

Reviewing editor

Johns Hopkins University School of Medicine

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your manuscript \"A robust activity marking (RAM) system for exploring neuronal activity\" as a Tools and Resources article to *eLife*. Three experts reviewed your manuscript, and the evaluation was overseen by Jeremy Nathans as the Reviewing Editor and a Senior Editor. Their assessments, together with my own, form the basis of this letter. As you will see, all of the reviewers were impressed with the importance and novelty of your work.

I am including the three reviews (lightly edited) at the end of this letter, as there are a variety of specific and useful suggestions in them. One point, in particular, that we noted is the limited overlap of P~RAM~ with Fos or *Npas4*. This needs to be explained.

As you will see, all of the reviewers were impressed with the importance and novelty of your work.

*Reviewer \#1:*

Manuscript 13918 by Sørensen et al. describes a new method to identify active neurons in vivo and to conditionally express transgenes. The method appears robust and adaptable to many uses. In my opinion the work presents an important advance and is suitable for publication in *eLife*.

The manuscript begins with a generalizable method to identify candidate cis elements and focuses on binding sites for *Npas4* and AP-1. They go on to demonstrate the robust inducibility and low basal in depolarized cultured neurons and then in vivo in response to context fear conditioning and kainic acid induced seizure. This looks to be superior to previous methods and so represents an important advance. I was surprised that there is a relatively small difference in [Figure 4](#fig4){ref-type="fig"} between A-A and A-B. This may make people worry that it is not really identifying behaviorally linked networks. I wonder why the authors did not look at CA1 neurons in a place field paradigm where the percentage of active neurons and network specificity is well established. Might the threshold activity required to induce the system be relatively high compared to Arc for example. If so, this should be mentioned in the manuscript. The strategy to confer Cre dependence presented in [Figure 5](#fig5){ref-type="fig"} is very nice. Did you ever see expression in parvalbumin neurons? Comment?

I would have liked to see a panel in [Figure 2D](#fig2){ref-type="fig"} looking at dentate 48 hrs after removal of Dox but without kainic acid.

[Figure 4](#fig4){ref-type="fig"} could benefit from a schematic showing the injection site.

Data in [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"} is very nice showing optogenetic control and might be substituted for panels E-G.

The statistical analysis and data provided appear appropriate.

*Reviewer \#2:*

Sørensen and colleagues have built a synthetic promoter (P~RAM~) toolkit that reports neuronal activation. Such a promoter can, in principle, be utilized in different ways to mark and manipulate a target neuronal population. The authors provide two such examples: incorporating P~RAM~ with a destabilized tTA in a tet-off system into a single AAV vector that can be used in vertebrate brains and using P~RAM~ to drive reporter expression in a Gal4 and Flp dependent manner in *D. melanogaster*. I think this system is likely to be widely used, and I am supportive of publication in *eLife*. In general the experiments are elegantly designed and executed, but I have a few concerns relating to the sensitivity and specificity of labeling of active neurons.

1\) The authors make strong claims about the superior sensitivity of their system compared to previous approaches. These may well be true, but it would nice to know how sensitive their system is in terms of detecting changes in neuronal activation. For example, what is the minimal percent increase in firing from baseline that is reliably reported by P~RAM~ ? A measure of sensitivity would also provide estimates of how much noisy fluctuations in firing will elicit P~RAM~ driven transcriptional activity. At the very least this should be discussed. The authors could also potentially test this in their primary neuronal cultures ([Figure 1](#fig1){ref-type="fig"}), ideally with channelrhodopsin mediated control of firing. Alternatively, rather than just testing P~RAM~ activity with 35mM KCl for 6 hours, a time course (say 2 and 4 hours) and a dose response to KCl would be informative. In these studies, it would be valuable to perform immunolabeling for c-Fos in parallel to compare this new approach to one that is familiar to most neuroscientists.

2\) Some controls appear to be missing for the in vivo studies relating to kainic acid induced seizures ([Figure 2](#fig2){ref-type="fig"}) and contextual or tone conditioning ([Figures 3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}). How many neurons express the reporter 24 hours following:saline rather than kainic acid injection;placement in the contextual testing chamber without being shocked;hearing the tone in the testing chamber without being shocked?

These controls will reveal how likely the neurons under consideration express reporter without the experimental manipulation being tested.

3\) I really appreciate the authors\' extending their validation of reporter induction to multiple brain regions and Glu and Gabaergic neurons. However, the number of reporter+ neurons is comparable between home cage and contextual conditioning paradigms (Figure 5---figure supplement 1A-C), so it\'s unclear whether reporter expression in Gabaergic Sst+ neurons (panel d) represents reporter induction in response to conditioning or basal expression seen in control home cage conditions.

As far as I can tell, there is no control for the aggressive social interaction test of reporter induction in the prefrontal cortex (Figure 5---figure supplement 1G-H). What is the level of basal reporter expression in the home cage in prefrontal cortex? A comparison between the control and aggression conditions would reveal whether there is reporter induction in the Gabaergic neurons in this region.

1\) Please provide a schematic of the experimental setup for the in vivo CRAM studies in [Figure 5](#fig5){ref-type="fig"}.

2\) Clarify what \"% overlap\" means as the y-axis label in [Figure 4G, H](#fig4){ref-type="fig"}.

3\) The first paragraph of the subsection "Application of the RAM System to Other Species" needs to be corrected; AAV-RAM was tested in rats and P~RAM~ was tested in flies.

4\) In the second paragraph of the subsection "Application of the RAM System to Other Species": cite study showing PFC projection to dorsal striatum.

5\) Correct discrepancy between Methods and Supplementary Figure legend: was the social interaction/aggression test done for 5 or 10 min?

6\) The authors will be depositing the basic AAV-RAM vector with Addgene. I also encourage them to deposit the CRAM version of the vector and other plasmids described here, including the ones for flies (but see below).

7\) Frankly, the fly data seem a bit rushed. For example, do we even know whether luciferase expression is even restricted to the nervous system? I would suggest that the authors hold on to the fly data and submit it as a more complete, separate story.

*Reviewer \#3:*

This manuscript by Sørensen et al. reports extensive characterization of a new tool for marking and manipulating neurons based on immediate early gene expression. This tool has the potential to be an important new addition to the arsenal for defining and manipulating cell populations based on neuron activity changes. They developed the RAM promoter, which gives improved signal to noise over past IEG systems and also is compact enough to fit easily inside an AAV vector. This promoter can be used to drive fluorescent proteins and optogenetic neuronal actuators. They go on to demonstrate the application of this tool in mice in a seizure model, contextual fear conditioning, auditory conditioning as well as other models in rat and fly. In addition, a Cre-dependent variant on the tool is described.

The tool depends on the tetOff tTA system, and doxycycline is administered to reduce background expression after viral expression and prior to the experiment. However, there is some ambiguity here because in the rat model, the dox was excluded and low background was apparently maintained. The use of dox appears to be important for the use of this tool, but the necessity of this component needs to be more explicitly expanded upon so that a future user is well-positioned to understand its importance. In addition, further explanation is required for the modest colocalization of Fos (note Fos, not c-Fos, is the MGI protein abbreviation) with mKate2 in [Figure 4](#fig4){ref-type="fig"} for the A-A conditions (only about 20%). Although this colocalization is significantly greater than the context A-B, there is no explanation why the colocalization is not higher. Because the expectation is that expression off of this promoter reflects IEG expression in neurons, this discrepancy is especially concerning as it is an essential aspect for application of this tool. Further examination or explanation of this issue is required.

10.7554/eLife.13918.028

Author response

*Reviewer \#1:*

*Manuscript 13918 by Sorensen et al. describes a new method to identify active neurons in vivo and to conditionally express transgenes. The method appears robust and adaptable to many uses. In my opinion the work presents an important advance and is suitable for publication in eLife.*

*The manuscript begins with a generalizable method to identify candidate cis elements and focuses on binding sites for Npas4 and AP1. They go on to demonstrate the robust inducibility and low basal in depolarized cultured neurons and then in vivo in response to context fear conditioning and kainic acid induced seizure. This looks to be superior to previous methods and so represents an important advance. I was surprised that there is a relatively small difference in [Figure 4](#fig4){ref-type="fig"} between A-A and A-B. This may make people worry that it is not really identifying behaviorally linked networks. I wonder why the authors did not look at CA1 neurons in a place field paradigm where the percentage of active neurons and network specificity is well established. Might the threshold activity required to induce the system be relatively high compared to Arc for example. If so, this should be mentioned in the manuscript. The strategy to confer Cre dependence presented in [Figure 5](#fig5){ref-type="fig"} is very nice. Did you ever see expression in parvalbumin neurons? Comment?*

The reviewer made the very insightful point that the CA1 region is much better established in a place field paradigm. We chose to focus on the dentate gyrus (DG) in this study mainly out of experimental convenience. The DG has been extensively examined in contextual fear conditioning (CFC), making it an excellent region to validate activity reporters. By targeting DG, not only can our results be conveniently compared to other published studies, it also allows us to examine the specificity of the RAM system using the A-A/A-B type of experiments ([Figure 4](#fig4){ref-type="fig"}). Being an important region for place field paradigm, CA1 should be thoroughly examined in the future.

There are two concerns raised about The A-A/A-B experiment (the original [Figure 4](#fig4){ref-type="fig"}). First, the low percentage (\~20%) of overlap between RAM+ and Fos+ neurons in the A-A experiment (Reviewer \#3). Second, the relatively small difference in overlap between A-A (\~22%) and A-B (\~13%) conditions (Reviewer \#1).

These are legitimate concerns. To address these concerns, we have carefully examined published studies. Since the behavioral manipulations involved vary considerably, the IEGs used for these experiments are not the same, and the quantification methods and statistical analyses also vary significantly, it is extremely difficult to directly compare numbers between studies. Nevertheless, we tried our best to compare our data to studies done in dentate gyrus using contextual fear conditioning. We found our results to be either comparable to or even more impressive than published studies. For example, a study from the Gage lab ([Figure 4](#fig4){ref-type="fig"} in Deng et al. *eLife* 2013;2:e00312) reported a \~6% overlap between Fos reporter (Fos-tTA::*tetO-tau-lacZ:tTA\**) positive and Fos+ neurons for A-A exposure. Another study from Dr. Rene Hen's lab ([Figure 3](#fig3){ref-type="fig"} in Denny et al. Neuron 83, 2014) showed a 5% or 4% overlap between the Arc-CreER reporter positive neurons and Fos+ or Arc+ neurons for A-A exposure, respectively. While the Gage study didn't detect a difference in overlapping population between A-A and A-B, the Hen study showed a significant difference between A-A (\~4%) and A-B (\~2%) conditions. Our data are perhaps best aligned with the study from the Tonegawa lab ([Figure 2](#fig2){ref-type="fig"} in Ramirez et al. Science 341, 2013), in which they reported, using a very different quantification method, \~1.8% vs. \~0.9% DAPI+ cells being doubly labeled by the Fos-tTA reporter and Fos antibody under A-A vs. A-B conditions. Assuming the Fos-tTA reporter labeled \~6% neurons following CFC (based on another study from the Tonegawa lab, [Figure 2](#fig2){ref-type="fig"} in Liu et al. Nature 484, 2012), for the Ramirez study we can estimate that \~30% and 15% of cells labeled by Fos-tTA were also Fos+ for A-A and A-B conditions respectively. This is comparable to our study. Critically, although the overall number of overlapping neurons varied wildly between studies, the trend is a roughly 2-fold increase in overlap between A-A and A-B conditions. In this respect, our data falls in line with the published literature. We have emphasized this point in the revised manuscript.

*I would have liked to see a panel in [Figure 2D](#fig2){ref-type="fig"} looking at dentate 48 hrs after removal of Dox but without kainic acid.*

This is basically the home cage control in [Figure 3C](#fig3){ref-type="fig"} and D.

*[Figure 4](#fig4){ref-type="fig"} could benefit from a schematic showing the injection site.*

A schematic showing the injection site has been included in the new [Figure 4A](#fig4){ref-type="fig"}.

*Data in [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"} is very nice showing optogenetic control and might be substituted for panels E-G.*

The optogenetic control is kept as supplementary data. Instead the Context Only condition has been added to [Figure 3](#fig3){ref-type="fig"}.

*Reviewer \#2:*

*Sørensen and colleagues have built a synthetic promoter (P~RAM~) toolkit that reports neuronal activation. Such a promoter can, in principle, be utilized in different ways to mark and manipulate a target neuronal population. The authors provide two such examples: incorporating P~RAM~ with a destabilized tTA in a tet-off system into a single AAV vector that can be used in vertebrate brains and using P~RAM~ to drive reporter expression in a Gal4 and Flp dependent manner in D. melanogaster. I think this system is likely to be widely used, and I am supportive of publication in eLife. In general the experiments are elegantly designed and executed, but I have a few concerns relating to the sensitivity and specificity of labeling of active neurons.*

*1) The authors make strong claims about the superior sensitivity of their system compared to previous approaches. These may well be true, but it would nice to know how sensitive their system is in terms of detecting changes in neuronal activation. For example, what is the minimal percent increase in firing from baseline that is reliably reported by* P~RAM~*? A measure of sensitivity would also provide estimates of how much noisy fluctuations in firing will elicit* P~RAM~ *driven transcriptional activity. At the very least this should be discussed. The authors could also potentially test this in their primary neuronal cultures ([Figure 1](#fig1){ref-type="fig"}), ideally with channelrhodopsin mediated control of firing. Alternatively, rather than just testing* P~RAM~ *activity with 35mM KCl for 6 hours, a time course (say 2 and 4 hours) and a dose response to KCl would be informative. In these studies, it would be valuable to perform immunolabeling for c-Fos in parallel to compare this new approach to one that is familiar to most neuroscientists.*

This is an excellent point. To the best of my knowledge, no one has systematically examined the activation sensitivity of any of the activity reporters being used in the field. Systematic characterization of activity reporters is very important for the neuroscience field and we are actively working on this using both in vitro and in vivo approaches. However, the process is quite involved. Most of the approaches we tried in vitro in cultured neurons, including using channelrhodopsin and KCl dosage as suggested by Reviewer \#2, turn out to be quite invasive and non-physiological. We are currently developing better methods to tackle this problem. As such, we don't have results to answer the question, but we have included this very important point in the Discussion.

*2) Some controls appear to be missing for the in vivo studies relating to kainic acid induced seizures ([Figure 2](#fig2){ref-type="fig"}) and contextual or tone conditioning ([Figures 3](#fig3){ref-type="fig"}, [5](#fig5){ref-type="fig"}). How many neurons express the reporter 24 hours following:saline rather than kainic acid injection;placement in the contextual testing chamber without being shocked;hearing the tone in the testing chamber without being shocked?*

*These controls will reveal how likely the neurons under consideration express reporter without the experimental manipulation being tested.*

There are some points regarding the activity induction of interneurons.

1\) Can RAM label activated PV+ neurons (Reviewer \#1)?

2\) Reviewer \#2 pointed out that the control for the social defeat experiment (original Figure 5---figure supplement 1G, H) was missing, making it unclear whether there is behaviorally-mediated reporter induction in the GABAergic neurons in the prefrontal cortex.

To address these concerns, we used inescapable stress paradigm to determine whether RAM labeling is induced in GABAergic neurons in the prefrontal cortex and if RAM can also label PV+ neurons. The answers to both questions are Yes. The result has been included in the revised manuscript, [Figure 7A-D](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1A-D](#fig7s1){ref-type="fig"}.

Reviewer \#2 requested the following control experiments.

1\) Saline injection control for kainic acid injection in the original [Figures 3](#fig3){ref-type="fig"} and 5. The purpose of the seizure condition in [Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"} was to demonstrate the infection efficiency of the RAM virus, not to compare seizure vs. non-seizure condition. The saline injection control is therefore unnecessary.

2\) Context without shock control in the original [Figure 3](#fig3){ref-type="fig"}.

We have included this control and, in addition, the immediate shock control in the revised manuscript ([Figure 3A-D](#fig3){ref-type="fig"}). Consistent with published studies showing context alone significantly induces IEG expressions, the number of RAM+ neurons for context only is numerically very similar to the context + shock condition. Also, the immediate shock didn't seem to activate RAM at all, which suggests neuronal ensembles labeled by RAM are specifically involved in contextual learning.

3\) Amygdala TFC sound only control in the original [Figure 5](#fig5){ref-type="fig"}.

We have now included both tone only and shock only controls for the TFC experiment in the revised manuscript ([Figure 5A-F](#fig5){ref-type="fig"}). In addition, we also included a comparison between LA and basal amygdala (BA). Our results are very much consistent with our current understanding of the functions of these two sub-regions of the amygdala, as well as IEG expression data for those regions after TFC. RAM only significantly labels LA under the tone + shock condition, but not by tone alone or shock alone. In contrast, all conditions significantly activated RAM in BA.

*3) I really appreciate the authors\' extending their validation of reporter induction to multiple brain regions and Glu and Gabaergic neurons. However, the number of reporter+ neurons is comparable between home cage and contextual conditioning paradigms (Figure 5---figure supplement 1A-C), so it\'s unclear whether reporter expression in Gabaergic Sst+ neurons (panel d) represents reporter induction in response to conditioning or basal expression seen in control home cage conditions.*

*As far as I can tell, there is no control for the aggressive social interaction test of reporter induction in the prefrontal cortex (Figure 5---figure supplement 1G-H). What is the level of basal reporter expression in the home cage in prefrontal cortex? A comparison between the control and aggression conditions would reveal whether there is reporter induction in the Gabaergic neurons in this region.*

*1) Please provide a schematic of the experimental setup for the in vivo CRAM studies in [Figure 5](#fig5){ref-type="fig"}.*

*2) Clarify what \"% overlap\" means as the y-axis label in [Figure 4G, H](#fig4){ref-type="fig"}.*

*3) The first paragraph of the subsection "Application of the RAM System to Other Species" needs to be corrected; AAV-RAM was tested in rats and* P~RAM~ *was tested in flies.*

*4) In the second paragraph of the subsection "Application of the RAM System to Other Species": cite study showing PFC projection to dorsal striatum.*

The above points have been addressed in the revised manuscript.

*5) Correct discrepancy between Methods and Supplementary Figure legend: was the social interaction/ aggression test done for 5 or 10 min?*

The social interaction/aggression experiment in mice has been replaced with inescapable stress experiment in rats.

*6) The authors will be depositing the basic AAV-RAM vector with Addgene. I also encourage them to deposit the CRAM version of the vector and other plasmids described here, including the ones for flies (but see below).*

As stated in the revised manuscript, both AAV-RAM and AAV-CRAM plasmids, from which other plasmids used in the study can be derived, have been at Addgene and will be available upon the publication of our manuscript.

*7) Frankly, the fly data seem a bit rushed. For example, do we even know whether luciferase expression is even restricted to the nervous system? I would suggest that the authors hold on to the fly data and submit it as a more complete, separate story.*

Although I agree with the reviewer that the fly data are not as thorough as we might prefer, I feel that the RAM promoter will be of great interest to the fly community. As far as I know, there is no good activity reporter currently available for use in the fly. Upon discussing with you, the fly data is kept in the revised manuscript.

*Reviewer \#3:*

*This manuscript by Sorenson et al. reports extensive characterization of a new tool for marking and manipulating neurons based on immediate early gene expression. This tool has the potential to be an important new addition to the arsenal for defining and manipulating cell populations based on neuron activity changes. They developed the RAM promoter, which gives improved signal to noise over past IEG systems and also is compact enough to fit easily inside an AAV vector. This promoter can be used to drive fluorescent proteins and optogenetic neuronal actuators. They go on to demonstrate the application of this tool in mice in a seizure model, contextual fear conditioning, auditory conditioning as well as other models in rat and fly. In addition, a Cre-dependent variant on the tool is described.*

*The tool depends on the tetOff tTA system, and doxycycline is administered to reduce background expression after viral expression and prior to the experiment. However, there is some ambiguity here because in the rat model, the dox was excluded and low background was apparently maintained. The use of dox appears to be important for the use of this tool, but the necessity of this component needs to be more explicitly expanded upon so that a future user is well-positioned to understand its importance. In addition, further explanation is required for the modest colocalization of Fos (note Fos, not c-Fos, is the MGI protein abbreviation) with mKate2 in [Figure 4](#fig4){ref-type="fig"} for the A-A conditions (only about 20%). Although this colocalization is significantly greater than the context A-B, there is no explanation why the colocalization is not higher. Because the expectation is that expression off of this promoter reflects IEG expression in neurons, this discrepancy is especially concerning as it is an essential aspect for application of this tool. Further examination or explanation of this issue is required.*

Reviewer \#3 pointed out that Dox was not used in experiments done in rats and wondered if the Dox control would work well in the rat. Although not included in the initial submission, we have also used Dox to control RAM expression in the rat, which yielded much more impressive labeling specificity. These experiments replace the old figure panels in [Figure 6A-D](#fig6){ref-type="fig"} in the revised manuscript.

[^1]: Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
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